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Abstract 
Copper plays a crucial role in human metabolism as a cofactor of enzymes responsible for 
respiration, iron metabolism, free radical disposal, and many other functions. Copper ATPases 
(Cu-ATPases) are a family of enzymes facilitating copper transport in the body. ATP7B is one of 
them, and it belongs to a P-type class of ATPases. In 1999, an mRNA of a splice variant (PINA) 
has been discovered in rat pineal gland and retina. Transcription levels of the mRNA increase 
during the night and decrease during the day. Homologous mRNA (ATP7B.K) was also reported 
in humans. 
The goals of this study were to confirm the expression of PINA in rat pineal gland, as well 
as to verify the temporal expression pattern. We also aimed to express and investigate the enzy-
matic activity of a recombinant putative PINA homologue from human, and compare its properties 
to the full-length ATP7B. 
We have successfully expressed the full-length ATP7B and two putative isoforms of human 
PINA homologue in K. lactis expression system. We have established a purification procedure that 
enabled us to get active enzymes and study their ATPase activity. This is the first successful puri-
fication of the active full-length human ATP7B reported. The activity of the full-length protein 
produced according to our procedure is comparable to previously reported by other groups, who 
studied either the full-length protein in the membrane or its purified truncated variants. The puta-
tive PINA homologues showed much higher ATPase activity than the full-length enzyme. 
We could not detect the putative PINA protein in pineal gland extracts and membrane prep-
arations due to low sensitivity of the available antibodies. Further investigations are needed for 
establishing copper transport rates of the full-length ATP7B and the PINA homologues, as our new 
protocol for copper transport quantification needs further optimizations. 
 
iii 
Acknowledgements 
I would like to express my gratitude to my scientific adviser, Dr. Oleg Dmitriev, for guid-
ance and support throughout the duration of the project. I would like to thank Dr. Nataliya Dolgova 
for her invaluable help. I would like to thank all members of Dmitriev lab for their advice and 
support, including but not limited to Chris O’Grady, Sergiy Nokhrin, Eva Uhlemann, Daryna 
Kulik, and Corey Yu. I would also like to thank my advisory committee members: Dr. Scot Leary, 
Dr. Miroslaw Cygler, and Dr. Scot Stone – for their advice and support. I would like to thank our 
collaborators and colleagues: Dr. Christopher Chang (California) for providing CS-1 fluorescent 
copper sensor, Dr. Hugh Goldie for help with large-scale yeast growth, Dr. George Katselis for 
help with mass spectrometry analysis. 
 
  
iv 
Table of Contents 
Permission to Use .......................................................................... Error! Bookmark not defined. 
Abstract ........................................................................................................................................... ii 
Acknowledgements ........................................................................................................................ iii 
Table of Contents ........................................................................................................................... iv 
List of Tables ................................................................................................................................. vii 
List of Figures .............................................................................................................................. viii 
List of Abbreviations...................................................................................................................... xi 
1. Introduction ......................................................................................................................... 1 
2. Background Information ..................................................................................................... 3 
2.1. Heavy Metals and Copper Homoeostasis ........................................................................... 3 
2.2. ATP7B as a Member of P-Type ATPase Family ................................................................. 6 
2.3. Circadian Rhythms in Metabolism ................................................................................... 16 
2.4. Pineal Gland and Melatonin .............................................................................................. 19 
2.5. PINA – Putative Copper Transporter from Pineal Gland .................................................. 21 
3. Materials and Methods ...................................................................................................... 25 
3.1. Molecular Biology Methods and Strain Description ........................................................ 25 
3.2. Plasmid Construction and Description .............................................................................. 26 
3.3. Protein Expression and Purification .................................................................................. 30 
3.3.1. Transformation and Expression in K. lactis ...................................................................... 30 
v 
3.3.2. K. lactis Culture Growth and Protein Expression ............................................................. 30 
3.3.3. Isolation of Membrane Fractions from K. Lactis Cells ..................................................... 31 
3.3.4. Affinity Purification of ATP7B and its Variants on Ni-NTA Agarose .............................. 31 
3.3.5. Size Exclusion Chromatography ....................................................................................... 32 
3.4. Proteoliposomes Preparation ............................................................................................. 33 
3.5. Activity Assays ................................................................................................................. 33 
3.6. Immunofluorescence and Microscopy .............................................................................. 35 
3.7. Rat Tissue Processing ........................................................................................................ 36 
3.8. Miscellaneous Methods ..................................................................................................... 37 
4. Results ............................................................................................................................... 39 
4.1. Expression of ATP7B and its variants in yeast Kluyveromyces lactis ............................... 39 
4.2. Protein Purification of ATP7B and its Variants ................................................................. 49 
4.3. ATPase Activity of the Purified ATP7B and its Truncated Variants ................................. 56 
4.4. Development of Copper Transport Assay for ATP7B Using CS-1 Fluorescent Sensor .... 60 
4.5. Detection of the Putative Copper Transporter PINA in Rat Pineal Gland ........................ 65 
5. Discussion ......................................................................................................................... 70 
5.1. Expression of ATP7B and its Variants .............................................................................. 70 
5.2. Purification of ATP7B and its Variants ............................................................................. 72 
5.3. Enzymatic activity of ATP7B variants. ............................................................................. 73 
5.4. Putative PINA ATPase Detection in Rat Pineal Gland...................................................... 77 
vi 
6. Conclusions ....................................................................................................................... 81 
7. Future Directions ............................................................................................................... 82 
8. References ......................................................................................................................... 83 
 
 
vii 
List of Tables 
Table 2.1: Classification of P-type ATPases...................................................................................7 
Table 3.1: Table of primers used in generation of plasmids..........................................................29 
  
viii 
List of Figures 
Figure 2.1. A scheme of copper transport in a mammalian cell .................................................... 4 
Figure 2.2. Homology model of ATP7B ....................................................................................... 9 
Figure 2.3. Schematic representation of ATP7B polypeptide ....................................................... 10 
Figure 2.4. Putative copper translocation channel in ATP7B ....................................................... 11 
Figure 2.5: Scheme of the catalytic cycle of PIB-type ATPases .................................................... 14 
Figure 2.6. Genetic map of ATP7B gene ...................................................................................... 15 
Figure 2.7. Human photoneuroendocrine system ......................................................................... 17 
Figure 2.8. Mammalian circadian master clock components ....................................................... 18 
Figure 2.9. Melatonin molecule .................................................................................................... 20 
Figure 2.10. Schematic view of domain composition of ATP7B .................................................. 23 
Figure 2.11. Model of putative PINA homologue from human .................................................... 24 
Figure 3.1. pKLAC2 plasmid map ................................................................................................ 27 
Figure 3.2. Map of pKLAC2-ATP7B vector ................................................................................ 28 
Figure 3.3. Map of pKLAC2-Δ1-795ATP7B and pKLAC2-ATP7B.K vectors .............................. 29 
Figure 4.1. Expression of the ATP7B variants in K. lactis detected by Western blotting ............. 40 
Figure 4.2. Recombinant ATP7B and ATP7B.K visualization in fixed K. lactis yeast cell by im-
munostaining (in false colours) ..................................................................................................... 41 
Figure 4.3. Distribution of the recombinant ATP7B and ATP7B.K proteins between various 
membrane fractions of K. lactis cells ............................................................................................ 42 
ix 
Figure 4.4. Solubilisation of the recombinant ATP7B protein from crude membrane fraction of K. 
lactis cells...................................................................................................................................... 43 
Figure 4.5. K. lactis yeast cells grown on YPGal-agar medium at various copper concentrations 
....................................................................................................................................................... 45 
Figure 4.6. Time course of Pi production by 35-50% membrane fraction of background strain of 
K. lactis cells, ATP7B and ATP7B.K transformants (Cu, BCS) ................................................... 46 
Figure 4.7. Time course of Pi production by 35-50% membrane fraction of background strain of 
K. lactis cells, ATP7B and ATP7B.K transformants (ATOX1-Cu) ............................................... 47 
Figure 4.8. Time course of Pi production by 35-50% membrane fraction of background strain of 
K. lactis cells (BkgdS) and Δ1-795ATP7B transformants (Cu, ATOX1-Cu, BCS) ......................... 47 
Figure 4.9. Comparison of specific ATPase activity in membranes of various transformants ..... 48 
Figure 4.10. Purification of ATP7B by Ni-NTA affinity chromatography of crude membrane ex-
tract ............................................................................................................................................... 51 
Figure 4.11. Purification of Ni-NTA-purified ATP7B by size-exclusion chromatography .......... 51 
Figure 4.12. Solubilisation of the recombinant ATP7B.K protein from crude membrane fraction 
of K. lactis cells............................................................................................................................. 52 
Figure 4.13. Purification of Δ1-795ATP7B by Ni-NTA affinity chromatography of crude mem-
brane extract .................................................................................................................................. 53 
Figure 4.14. Purification of Ni-NTA purified Δ1-795ATP7B by size-exclusion chromatography. . 53 
Figure 4.15. Purification of ATP7B.K by Ni-NTA affinity chromatography of crude membrane 
extract. ........................................................................................................................................... 54 
Figure 4.16. Purification of Ni-NTA purified ATP7B.K by size-exclusion chromatography ....... 55 
Figure 4.17. SYPRO Ruby stained SDS polyacrylamide gel of purified ATP7B and its variants 
....................................................................................................................................................... 55 
x 
Figure 4.18. Specific activity of ATP7B and its variants reconstituted into asolectin liposomes 
estimated from single point measurements in MES buffer with 1 mM ascorbic acid and 100 µM 
TCEP ............................................................................................................................................. 57 
Figure 4.19. Specific activity of ATP7B and its variants reconstituted into asolectin liposomes 
estimated from single point measurements in MES buffer with 100 µM TCEP .......................... 58 
Figure 4.20. Time course of Pi production by ATP7B and its two variants in MES buffer with 100 
µM TCEP ...................................................................................................................................... 59 
Figure 4.21. Time course of Pi production by ATP7B.K in MES buffer with 100 µM TCEP, 
smaller time step ........................................................................................................................... 59 
Figure 4.22. Chemical structure of CS-1 ...................................................................................... 60 
Figure 4.23. Dependence of CS-1 fluorescence in response to various copper and copper-ATOX1 
concentrations in MES-AT buffer ................................................................................................. 61 
Figure 4.24. Principle scheme of CS-1 fluorescence copper transport assay. .............................. 62 
Figure 4.25. Time course of CS-1 response to different combinations of asolectin, ATOX1 and 
Cu+ in MES buffer with 1 mM ascorbate and 0.1 mM TCEP ...................................................... 64 
Figure 4.26. Time course of CS-1 response to different combinations of liver lipid, ATOX1 and 
Cu+ in MES buffer with 1 mM ascorbate and 0.1 mM TCEP ...................................................... 64 
Figure 4.27. Time course of CS-1 response to transport activity of ATP7B reconstituted into aso-
lectin liposomes in MES-AT buffer .............................................................................................. 65 
Figure 4.28. Testing antibodies for ATP7B detection in rat liver tissue ....................................... 66 
Figure 4.29. Western blot of ATP7B.K in whole cell extracts of K. lactis cells ........................... 67 
Figure 4.30. Western blot of rat pineal gland tissue extract, anti-ATP7B ..................................... 68 
Figure 4.31. Western blot of rat pineal gland membrane fraction ................................................ 69 
xi 
List of Abbreviations 
BCA – bicinchoninic acid 
BCS – bathocuproinedisulfonic acid 
cAMP – cyclic adenosine monophosphate 
CCG – clock-controlled gene 
CHAPS – 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate 
CHO – Chinese hamster ovary cells 
COS – CV-1 (simian) origin SV-40-immortalized cells 
COX – cytochrome c oxidase 
CREB – cis-response element binding protein 
DDM – dodecyl maltoside 
DMSO – dimethyl sulfoxide 
CRX – cone-rod homeobox 
CV – column volume 
DTT – dithiothreitol 
GABA – γ-aminobutyric acid 
GFP – green fluorescent protein 
HEPES – 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HIOMT – acetylserotonin O-methyltransferase 
HRP – horseradish peroxidase 
HSP – heat shock protein 
ICER – inducible cAMP early repressor 
LMPG – 1-myristoyl-2-hydroxy-sn-glycero-3-phosphocholine (lyso-myristoyl phosphatidyl 
glycerol) 
MBD – metal-binding domain 
MES – 2-(N-morpholino)ethanesulfonic acid 
xii 
NAT – N-acetyltransferase 
Ni-NTA – nickel-nitriloacetic acid 
NMR – nuclear maginetic resonance 
ORF – open reading frame 
PBS – phosphate buffered saline 
PrPC – prion protein cellular isoform 
PVN – paraventricular nucleus 
PINA – pineal night-specific ATPase 
ROS – reactive oxygen species 
SCN – suprachiasmatic nucleus (nuclei) 
SDS – sodium dodecyl sulfate 
SDS-PAGE – sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SOD – Superoxide dismutase 
TCEP – tris(2-carboxyethyl)phosphine 
TGN – trans-Golgi network 
TM – transmembrane helix 
UTR – untranslated region 
 
 
1 
1. Introduction 
Copper plays a crucial role in human metabolism. It is involved in many crucial processes, 
such as cell growth, angiogenesis, oxidation stress protection, and tumour growth. It works pri-
marily as a cofactor of various enzymes, providing many physiological functions, such as respira-
tion, iron metabolism, free radical disposal, and connective tissue formation (Festa and Thiele, 
2011). 
A number of proteins is responsible for maintaining copper homoeostasis. Copper ATPases 
(Cu-ATPases) are a family of enzymes facilitating copper transport. They are membrane proteins 
that transport copper from cytosol to secretory pathways and enzymes (Steveson et al., 2003; Guo 
et al., 2005). 
One of two known copper ATPases in human body, ATP7B, plays the major role in copper 
regulation in the liver, where it is responsible for excretion of excess copper from the body into 
the bile (Linder et al., 1998). Another major function of the enzyme in all tissues where it’s present 
is incorporation of copper into certain enzymes, such as superoxide dismutase (SOD) (Culotta et 
al., 2006), as well as into ferroxidase ceruloplasmin (Punter and Glerum, 2003; Prohazka and 
Gybina, 2004; Barnes et al., 2005; Horng et al., 2008). 
The genetic deficiency in ATP7B leads to a condition known as Wilson’s disease. It is 
characterized by an excessive accumulation of copper in the tissues, especially in the liver and the 
brain. It manifests in liver malfunction and neurological symptoms, and is fatal if untreated.  
Several alternative splicing variants of the ATP7B gene are known (Bull et al., 1993; 
Petrukhin et al., 1994; Borjigin et al., 1999; “AceView”, 2015; “Entrez”, 2015), with PINA (Pineal 
Night-Specific ATPase) seeming the most interesting in terms of its structure and functions. It is 
expressed primarily in the pineal gland (hence its name) and in the retina. The expression has a 
strong diurnal dependence both in the retina and in the pineal, with a 100-fold increase in tran-
scription levels during the night compared to daytime (Borjigin et al., 1999). Structurally, PINA is 
peculiar: it misses a significant part of the N-terminus in comparison with ATP7B, but it retains 
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elements of structure essential for copper transport. An mRNA of putative human homologue of 
PINA, ATP7B.K has also been reported (Totoki et al., 2005).  
We propose that PINA represents a novel splice variant of P-type ATPases with yet un-
known function and novel catalytic mechanism, which is involved in circadian regulation of cop-
per metabolism. 
Because copper is involved in many important processes, understanding the properties of 
PINA protein could shed light on interaction between circadian rhythms and biochemical processes 
in the organism. Recent research has shown that disruption of circadian rhythms caused by tech-
nological development of modern civilization (for example, ability to have light 24 hours a day, 
jet-lags, shift work, etc.) leads to development of many serious disorders, from constant fatigue to 
diabetes and cancer. Currently mechanisms of circadian rhythm regulations and their interaction 
with functions of other organs and processes in the organisms are not very well understood. 
In this study, we aimed to confirm presence of the protein product of PINA mRNA in rat 
pineal gland and check whether or not protein expression also shows circadian rhythm dependence, 
as well as to express, purify and characterize enzymatic activity of putative human homologue of 
PINA in comparison with ATP7B. 
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2. Background Information 
2.1. Heavy Metals and Copper Homoeostasis 
Heavy metals are those metals and metalloids which have a relatively high density and are 
toxic at low concentrations (Srivastava and Goyal, 2010). Among these are chromium, cobalt, 
nickel, copper, zinc, arsenic, mercury, lead, platinum group of elements, and other metals and met-
alloids. 
Despite being toxic, many of these elements play important biological functions. Zinc, for 
example, is a very important trace element for humans and animals, plants and microorganisms 
(Stipanuk, 2006; Nakashima and Dyck, 2009). The major role of cobalt is in vitamin B12 (cobal-
amin). Arsenic is a highly toxic metalloid. Nevertheless, it has been shown to have an unknown 
essential role in metabolism of higher animals (Uthus, 1992). Some bacteria are capable of oxida-
tion of arsenic compounds to produce energy (Mukhopadhyay et al., 2002). Cadmium is renowned 
for its environmental toxicity; however, it was recently shown to play a biological function in 
carbonic anhydrase in some marine diatoms (Lane et al., 2005). Copper also follows the pattern, 
being both beneficial and harmful, depending on the amounts. 
Copper is 26th most abundant element in the Earth crust. Only small part of that copper is 
present in soils in form available to living organisms. In fact, it’s the observations on poor plant 
growth and animals’ health issues in regions with low soil copper content that led to understanding 
of an importance of copper for living organisms (Linder, 2013). 
Copper is very important for energy metabolism, being a cofactor in cytochrome c oxidase, 
an enzyme common for all aerobic organisms. It also plays an important role in connective tissue, 
where extracellular cuproenzyme lysyl oxidase cross-links elastin and collagen. Other roles in-
clude reactive oxygen species (ROS) detoxification (superoxide dismutase, SOD), production of 
melanin (tyrosinase), nerve functions and metabolism (dopamine β-hydroxylase). Ceruloplasmin, 
a ferroxidase, also relies on copper for its functions (Linder, 2013). 
The ability of copper to shift between two oxidation states – Cu+ and Cu2+ – allows it to 
facilitate redox reactions by the enzymes. The same ability is also a reason for copper toxicity: 
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redox conversion of copper in tissues and cells starts free radicals chains following Fenton and 
Harber-Weiss mechanism in aerobic conditions: 
O2
•- + Cu2+ → O2 + Cu+ 
Cu+ + H2O2 → Cu2+ + HO• + OH− 
Cu2+ + H2O2 → Cu+ + HOO• + H+ 
Hydroxyl and hydroxyperoxyl radicals are very powerful oxidants, and are capable of caus-
ing a lot of damage to proteins, lipids and DNA, ultimately leading to cell death. For this reason, 
copper is not present in the cell as a free ion. It is usually bound to copper chaperons and small 
molecules. Another way of exhibiting toxicity for copper is by acting as a high affinity ligand for 
methionine, cysteine and histidine residues in proteins, which leads to displacement of other metal 
ions from active sites and to protein misfolding (Banci et al., 2010). 
 
Copper transport in the cell is regulated by a network of copper-transporting proteins (Fig. 
2.1). Copper uptake by the cell is facilitated by CTR1, a copper importer located in the plasma 
membrane. Cellular localization of the importer depends on the extracellular copper content: CTR1 
 
Figure 2.1: A scheme of copper transport in a mammalian cell. Reprinted by permission from Macmillan Pub-
lishers: Nature (Bartnikas and Gitlin, 2001), copyright 2001. 
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is internalized to prevent excessive copper uptake when there’s too much copper in the extracellu-
lar space, while low levels of copper lead to redistribution of the importer back to the plasma 
membrane (Molloy and Kaplan, 2009). Requirements of the cell itself also play a role: an increased 
demand for copper intake or release up- or downregulates the protein, as well as rearranges its 
localization. 
When copper is inside the cell, it is taken from CTR1 by copper chaperones, like ATOX1 
(7.4 kDa protein which delivers copper to trans-Golgi network, TGN) and CCS (54 kDa cytosolic 
protein which delivers copper to Cu,Zn-SOD). There are probably other unknown intermediate 
carriers, which aid delivery of copper to mitochondria. 
ATOX1 is a small cytosolic protein which binds Cu+ ion with 1:1 stoichiometry. Its first 
discovered role was protection of cells from oxidative stress, hence the name, Antioxidant protein 
1. Later it was discovered that it plays an essential role in copper trafficking in a cell, in particular, 
shuttling of copper to TGN to ATP7A and ATP7B copper ATPases, which then facilitate copper 
integration into cuproenzymes or copper excretion from the cell (Lutsenko et al., 2007). Another 
recently discovered role of ATOX1 is a copper-dependent cyclin D1 transcription activator, play-
ing a role in cell proliferation (Itoh et al., 2008). 
Copper ATPases ATP7A and ATP7B which receive copper from ATOX1 are generally lo-
calised in TGN or plasma membrane. ATP7B protein is co-expressed in many tissues together with 
ATP7A; however these two proteins seem to have different roles and regulation (Lutsenko et al., 
2007). For example, in choroid plexus cells ATP7B performs removal of excess copper from brain 
tissue to blood, while ATP7A pumps copper from circulation to the brain cells and cerebrospinal 
fluid (Nevitt et al., 2012). 
ATP7A plays an essential role in copper uptake in the intestine, pumping copper across the 
basolateral membrane of intestinal epithelial cells to the peripheral blood flow, and in the brain 
across the blood brain barrier (Nevitt et al., 2012). In other tissues, for example in kidneys, it 
removes excess copper from the cells and supplies certain enzymes with copper, namely, peptidyl-
α-monooxygenase, tyrosinase, and lysyl oxidase (Lutsenko et al., 2008). The gene encoding 
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ATP7A is located on the X chromosome. The defects in ATP7A result in Menkes disease, a fatal 
copper uptake disorder, which leads to death at a very young age (Menkes et al., 1962). 
ATP7B is a sole copper ATPase in the liver, where it plays both biosynthetic and export 
roles (Tanzi et al., 1993). Its major role is loading of cuproenzymes (for example, apo-ceruloplas-
min) with copper ions in trans-Golgi network. It also secretes copper to blood plasma and excretes 
it into the bile. Its gene is located on the chromosome 13, and several splice variants are known 
(“AceView”, 2015; “Entrez”, 2015). Deficiency in this protein leads to Wilson’s disease with 
symptoms of copper overloading, which manifests in very high copper content mostly in liver and 
brain. This, if untreated, leads to liver failure and severe neurological disorders. 
Storage of copper is carried out mostly by metallothioneins (MTs) – small cysteine rich 
polypeptides, which can bind up to 12 copper ions, sequestering them from cytoplasm (Nevitt et 
al., 2012). Metallothioneins are rapidly induced in a response to elevation of level of metals (such 
as copper, but also other heavy metals). Not only these proteins provide protection against delete-
rious effects of excess heavy metals, but they can also serve as a depot for copper and release it in 
conditions of copper deficit (Ogra et al., 2006). 
Another labile pool of copper in the cell is represented by small molecules, such as gluta-
thione (Nevitt et al., 2012). Experimental depletion of GSH levels in liver showed a disruption in 
normal copper metabolism (Ogra et al., 2010). This disruption could result from several concurrent 
effects, for example, decrease of copper bioavailability due to oxidative environment, or inhibition 
of ATP7A/B pumps by low GSH levels. GSH was found to be capable of loading SOD1 directly 
(Nevitt et al., 2012), so another reason for the disruption could be the lack of direct loading of the 
ATPase pumps. This complex regulation system ensures copper balance in the cell. 
2.2. ATP7B as a Member of P-Type ATPase Family 
Copper-transporting ATPases belong to a P-type family of ATPases. P-type ATPases com-
prise a vast and ubiquitous family of membrane-localized enzymes that are involved in transport 
of ions and lipids.  
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Table 2.1: Classification of P-type ATPases 
Class Substrate Features, functions and examples 
ⅠA K+ Bacterial KdpB is a part of a larger K+-transporting complex, functions as 
ATPase only (Kühlbrandt, 2004) 
ⅠB Soft Lewis acids: Cu+, 
Ag+, Cu2+, Zn2+, Cd2+, 
Pb2+, and Co2+ 
Provide metalloenzymes with the metal cofactors, excrete toxic metals 
(Nucifora et al., 1989; Rensing et at, 1999). Single polypeptide. Mem-
bers of the class: ATP7A, ATP7B, CopA, ZntA, and others. Possess 
metal-binding domains. 
ⅡA Ca2+ Prokaryotic (Deves and Brodie, 1989) and eukaryotic Ca2+-transporters. 
Regulated by phospholamban and sarcolipin (Asahi et al., 2003). SERCA 
is the best-studied P-type ATPase with solved crystal structure (Palmgren 
and Nissen, 2011). 
ⅡB Ca2+, Mn2+ Eukaryotic plasma membrane Ca2+-transporters (Brini and Carafoli, 
2009) or Mn2+-transporters in Golgi (Mandal et al., 2003). Regulated by 
calmodulin (Scharff and Foder, 1978).  
ⅡC Na+/K+, H+/K+ Na/K-ATPase is responsible for maintaining membrane potential, H/K-
ATPase acidifies gastric lumen. These proteins usually have at least one 
supporting subunit, which can prevent pumping ions in reverse (Abe et 
al., 2009). 
ⅡD Unknown Unknown, found in fungi. 
ⅢA H+ Found in plants and fungi, where they help to maintain membrane poten-
tial (Kühlbrandt, 2004) 
ⅢB Mg2+ Found in bacteria, closely related to ⅢA (Kühlbrandt, 2004) 
Ⅳ Phospholipids Maintain lipid bilayer asymmetry by flipping lipid molecules from one 
side of the bilayer to another. The second proposed function of these en-
zymes is initiation of budding of membrane vesicles. 
ⅤA Unknown, putatively 
phospolipids 
Orphan transporters that have P-type ATPase signatures, otherwise un-
characterised (Sørensen et al., 2010) 
ⅤB Unknown 
 
These intricate molecular machines perform a variety of roles, which are very important 
for metabolism: they mediate cellular signalling, build electrochemical gradients, initiate vesicle 
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budding, detoxify cellular environment, load metalloenzymes with metal ions, and regulate mem-
brane composition. P-type ATPases can be found in all living organisms. 
The classification of P-type ATPases is based on conserved core sequences found among 
all members of the family (Axelsen and Palmgren, 1998). They are divided into five major sub-
families, which are further subdivided into several classes (Table 2.1). 
ATP7B together with other heavy metal pumps belongs to a PIB class of ATPases. It’s a 
single polypeptide (157 kDa) with a complex domain structure (Fig. 2.2). The core structure is 
similar to all other P-type ATPases and consists of the soluble A, P, N domains, and the transmem-
brane S and T domains. The ATPase activity is performed by the soluble domains. The movements 
caused by ATP hydrolysis induce conformation changes in the transmembrane domains, thus cou-
pling the hydrolysis to translocation of ions. 
No crystal structure of ATP7B has been solved to date. The best available model is a ho-
mology model of ATP7B created recently (Schushan et al., 2012). 
Homology modelling is based on the assumption that the secondary structure elements are 
more conserved than the primary amino acid sequence. The method of homology modelling uses 
known 3D-structures of homologous proteins which are used as templates for alignment. A model 
is built after aligning the sequences, and is assessed for geometrical validity (Nugent and Jones, 
2009). 
The quality of a model depends on compatibility of a template and sequence similarity. 
With the sequence similarity above 30% modelled membrane proteins were showed to deviate not 
more than 2 Å from the native structure (Forrest et al., 2006). X-ray structures of several members 
of the family have been successfully solved, including CopA from A. fulgidus and L. pneumonia, 
as well as individual domains of various P-type ATPases (Toyoshima et al., 2000; Pedersen et al., 
2007; Hakansson, 2009; Tsuda and Toyoshima, 2009; Gourdon et al., 2011; Wu et al., 2011; and 
others). The similarity of ATP7B sequence and CopA from L. pneumonia is around 35%, which 
gives quite a reliable model. 
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The P-domain and the N-domain are a part of a single cytosolic loop (ATP-binding loop or 
domain, ATP-BD). The P-domain contains a β-sheet surrounded by three α-helices (Dmitriev et 
al., 2006). The invariant Asp residue in the P-domain (in conserved DKTG sequence) undergoes 
transient phosphorylation by a phosphate from ATP molecule during the catalytic cycle. Conserved 
sequences TGDN and GDG play role in Mg2+ coordination. Overall, P-domain shows higher de-
gree of conservation among different P-type ATPases, and shows homology with haloacid dehalo-
genase superfamily (Aravind et al., 1998). 
 
 
Figure 2.2: Homology model of ATP7B. Yellow – A-domain, cyan – ATP-binding domain (P- and N-domains), 
Red – transmembrane domain (S- and T-domains). MBDs are denoted as dotted circles for illustrative purposes 
(from Schushan et al., 2012, with modifications) 
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The N-domain binds the ATP molecule and phosphorylates the P-domain. It has consider-
able sequence variability inside the family, but the core is conserved (Kühlbrandt, 2004). The N-
domain of PIB-ATPases has a stronger similarity with that of PIA-ATPase KdpB (Dmitriev et al., 
2006). The conserved SEHPL is involved in nucleotide binding. The mutation of the histidine 
residue impairs binding of ATP and as a result the catalytic function of the enzyme (Tsvikovskii et 
al., 2003). This domain is the least conserved among copper ATPases between different phyla. In 
comparison with bacterial copper ATPases, the eukaryotic enzymes have an insert between β-
strands 3 and 4, which is longer in more evolutionarily advanced species, i.e. it’s very short in 
yeast, longer in plants and lower vertebrates, and the longest in mammals. This sequence is not 
involved in ATP binding, and is proposed to have a regulatory role (Gupta and Lutsenko, 2011). 
The A-domain of ATP7B exhibits a protein phosphatase activity. It has been found (Xu et 
al., 2002) to come into a close contact with the phosphorylation site in the P-domain. The main 
role in this process belongs to the TGE conserved sequence, which is involved in hydrolysis of the 
aspartate-Pi bond in the P-domain’s DKTG motif: the glutamate residue orients a water molecule 
in a position suitable for the hydrolysis and release of the phosphate. The A-domain is attached to 
the membrane component of the enzyme via flexible linkers to TM2 and TM3 helices. It has been 
 
Figure 2.3: Molecular architecture of WNDP. (A) The predicted transmembrane organization of WNDP. The 
cylinders in the N-terminal portion with the CxxC motif represent the cytosolic copper-binding sites. TGE, 
TGDN, and GDG are the sequence motifs conserved in all P-type ATPases. D in a circle is an invariant Asp 
residue in the DKTG sequence motif that is phosphorylated during ATP hydrolysis. CPC and SEHPL are the 
sequence motifs characteristic of the P1-type ATPases. Other letters mark location of the amino-acid residues 
highly conserved in the copper-transporting ATPases. (from Lutsenko et al., 2002). Reprinted with permission 
of Springer. 
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shown that proteolytic cleavage of these linkers renders the enzyme inactive, because it breaks 
conformational inter-domain communications necessary to go through the stages of the catalytic 
cycle, at least as observed in SERCA (Møller et al., 2002; Lenoir et al., 2004). The movement of 
helices connected to the A-domain opens and closes the gate for ion translocation pathway 
(Kühlbrandt, 2004). The rotation of the domain also influences the rate of the enzyme turnover by 
controlling the rate of protein dephosphorylation (Argüello et al., 2007). The A-domain of PIB-
type ATPases is structurally different from A-domains of PII-type and PIII-ATPases: it is smaller 
and does not have a separate N-terminal subdomain formed by a preceding cytosolic loop. 
The transmembrane part of the enzyme consists of eight helices. The first two belong to 
the more rigid S-domain, and the rest – to the more flexible T-domain (Palmgren and Nissen, 
2011). Of these, the last three contain the sequences that appear to be essential for copper translo-
cation (Fig. 2.3 and Fig. 2.4, C). The CPC motif is located in the transmembrane helix 6 (TM4). 
This motif is conserved in all ATPases which are involved in transition metal transport (Bissig et 
al., 2001). The M5 contains YN residues which are conserved among all ATPases known or pre-
dicted to transport copper (Lutsenko et al., 2002), and the M6 contains a conserved MxxSS frag-
ment. The second transmembrane helix (TMB), which belongs to the S-domain, has an almost 
perpendicular kink, which results in part of the TMB lying on the interface of the membrane and 
the cytosol (Sitsel et al., 2015). 
 
 
Figure 2.4: Putative copper translocation channel in ATP7B (from Schushan et al., 2012). Reprinted by permis-
sion of Royal Society of Chemistry. 
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The homology model, as well as previous knowledge of P-type ATPase structure and func-
tion based on crystal structures of SERCA and Na/K-ATPase, helps to get an insight on copper 
translocation channel through the transmembrane domain. The putative entry site for Cu+ ions is 
located near the kinked TMB segment, and is putatively formed by residues in TM1 (N728, M729, 
D730), TM2 (R778, E781, K785), TM3 (D918), and behind TM4 (E1016). The importance of 
these residues has been established by analyzing ATP7B from Wilson’s disease patients and by 
comparing them with CopA. M729, E781, and D918 are conserved and are suggested as the most 
important in copper uptake by enzyme. Other residues were shown to be otherwise clinically im-
portant in ATP7B (Fig. 2.4, B) (Schushan et al., 2012). 
The ion-binding site is located further inside the transmembrane domain, and is formed by 
residues located in TM4 (C980, C983, C985) and TM6 (M1359). C983 and C985 belong to the 
conserved CPC motif, and are essential for copper transport (Forbes and Cox, 1998). The two 
cysteines of the motif and the methionine form a trigonal coordination plane for a single Cu+ ion. 
The YN motif in TM5 (Y1331, N1332) and MS in TM6 (M1359 and S1369) is also conserved 
between CopA and ATP7B, as well as other Cu+-ATPases (Schushan et al., 2012). Another model, 
based on Archaeoglobus fulgidus CopA studies, proposed that these residues are needed to form 
another trigonal planar copper binding site. The same analysis suggested that CopA transports two 
copper ions per one ATP molecule hydrolysed (González-Guerrero et al., 2008). Transport of coun-
ter-ions is not known for Cu+-ATPases, although it’s a usual feature of other P-type ATPases, such 
as Na/K-ATPase and SERCA (counter-ion: H+).  
The exit site exhibits a lesser degree of conservation between CopA and ATP7B. In ATP7B, 
the site is comprised of residues in TMA (M669), TM2 (D765, M769), and M1359, which can also 
be putatively involved in formation of the second internal binding site for a copper ion. Clinically 
important mutations in the first three mentioned residues reduce the rate of turnover of the enzyme 
(Schushan et al., 2012). 
A distinctive feature of ATP7B, as of other PIB-ATPases, is its N-terminal region, which 
consists of six metal binding domains (MDB1-6) which have a ferredoxin-like fold and one CXXC 
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metal binding motif per domain (Arnesano et al.,2002). The N-terminus of copper ATPases ap-
pears to have mainly regulatory functions. The first 63 amino acids of the N-terminus, which are 
not involved in copper binding, are important for trafficking of ATP7B to the apical membrane of 
polarised cells in high copper concentration (Guo et al., 2005). Trafficking is also regulated by 
phosphorylation at several sites in the N-terminus (Vanderwerf et al., 2001). Not only phosphory-
lation, but also interactions between the individual MBDs of the N-terminus can induce intracel-
lular trafficking of human ATP7B (Huang et al., 2014). 
MBDs can also regulate enzyme activity. It has been shown that MBDs can regulate the 
rate of the enzyme by interacting with the A-domain and N-domain (Tsvikovskii et al., 2001; Hus-
ter and Lutsenko, 2003). The metal-binding domains in PIB-ATPases are not needed for metal 
transport itself. Recent studies demonstrate that PIB-ATPases are capable of heavy metal transport 
even in absence of the MBDs (Baekgaard et al., 2010; González-Guerrero and Argüello, 2008). 
Furthermore, it is the core of the enzyme and not MBDs that determines ion specificity of the 
pump (Fatemi and Sarkar, 2002). Usual number of MBDs in organisms that sit low on the evolu-
tionary ladder – bacteria and lower eukaryotes – is two. PIB-ATPases of evolutionarily higher or-
ganisms usually have more MBDs, up to six in human ATP7A and ATP7B (Gupta and Lutsenko, 
2012). 
The initial ideas on the function of MBDs and N-terminus regarded them as necessary for 
copper translocation by accepting copper from chaperones and transporting it downstream to the 
transmembrane domain. However, more recent evidence shows that copper chaperones, such as 
CopZ in bacteria or ATOX1 in mammals, are capable of delivering Cu+ ions to the MBDs and the 
protein core alike, and a separate copper-loaded MBD cannot transfer ions to the core (González-
Guerrero and Argüello, 2008; Fu et al., 2013). The deletion of MBDs from A. fulgidus CopA 
showed to have little or no effect on ATPase activity of the enzyme in the presence of Cu+ (Gon-
zález-Guerrero and Argüello, 2008). Interestingly, it has been reported, that in E. coli at least one 
metal-binding domain is needed for copper resistance in vivo (Fan et al., 2002), but CopA from E. 
coli preserves its activity even in the absence of all domains in vitro (Drees et al., 2015). In ATP7A, 
tested in enriched Golgi fraction from CHO cells, mutation of all copper-binding CXXC motifs 
did not alter the activity of the enzyme (Voskoboinik et al., 1999). A different experiment, however, 
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showed that at least one copper-binding motif in either MBD5 or MBD6 of ATP7B is needed for 
proper functioning of the enzyme (Huster and Lutsenko, 2003). 
 
Another distinctive feature of ATP7B is its long C-terminal tail, which resides on the cyto-
plasmic side together with all other soluble domains, and is 80 amino acids long. In the C-terminus, 
there are three conserved Leu residues. In ATP7A there’re two Leu residues which are known to 
play role in its trafficking (Petris et al., 1998). No structural data is available for this region. 
The catalytic mechanism of ATP7B, as of all P-type ATPases, is described by Post-Albers 
cycle (Albers et al., 1963; Post and Sen, 1965). The scheme originally described a mechanism of 
Na/K-ATPase, and defined two distinctive states: E1 (inward-open, high affinity for exported ions) 
and E2 (outward-open, high affinity for imported ions) (Jardetsky, 1966). Currently, more distinct 
conformational states, which drive ATP hydrolysis and substrate translocation, are defined 
(Kühlbrandt, 2004; see Fig. 2.5). 
 
Figure 2.5: Scheme of the catalytic cycle of PIB-type ATPases. Green - copper ion, light blue - S-domain, grey - 
T-domain. Domain movements are indicated by coloured arrows. Reprinted with permission from Sitsel et al., 
2015. Copyright (2015) American Chemical Society. 
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In E1 state the protein is inward-open, and the ion-binding site has high affinity for copper 
ions. Ion binding induces conformational changes which promote binding of ATP to the N-domain 
(E1-ATP). This transition occludes the ion binding site, and the P-domain gets phosphorylated at 
the invariant Asp residue in the DKTG motif (E1P-ADP), while β-γ phosphate bond of the ATP is 
broken, and the ADP is released. The protein undergoes a large conformational change, turning 
outward-open, the affinity for the exported ion decreases, and the ion gets released. The release of 
the ion leads to the binding site occlusion and phosphate release from the protein, which leads to 
transition to E2 state, which then transitions to E1 state (Bublitz et al., 2010; Sitsel et al., 2015). 
This mechanism is common for all P-type ATPases, with the exception that many of them also 
transport a counter-ion in an opposite direction. 
The complete ATP7B gene sequence was determined in 1994. It is a large gene with a size 
of approximately 80 kb; it has 21 exons 77 to 1234 bp in length (Fig. 2.6) with the start codon for 
the initiating Met situated within exon 1 (Petrukhin et al., 1994). 
 
Several alternative splicing variants of the gene are known (Bull et al., 1993; Petrukhin et 
al., 1994; Borjigin et al., 1999, see “AceView”, 2015). It was found that the alternative splicing of 
the ATP7B gene can be tissue-specific, and might be a form of gene regulation. Some cDNAs 
obtained from brain tissue were shown to sometimes exclude regions of the protein which are 
crucial for its functionality, for example, ATP-binding motif. Thus, some of alternative splicing 
events seem to play regulatory role, by decreasing quantities of an active enzyme. However, it 
cannot be excluded that some of splicing events produce functional variants of ATP7B with dif-
ferent properties than the normal protein, for example missing exons 6-7-8 in some brain-derived 
cDNA clones which encode for an N-terminal segment of the M-domain (Petrukhin et al., 1994). 
PINA (Pineal Night-Specific ATPase) is an interesting splice variant in terms of its struc-
ture and functions. It is expressed primarily in the pineal gland (hence its name) and in the retina. 
 
Figure 2.6: Genetic map of ATP7B gene. Rectangles represent exons, while jagged lines represent introns, num-
ber of supporting reads/accessions indicated (from “AceView”, 2015) 
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The expression has a strong diurnal dependence both in the retina and in the pineal, with a 100-
fold increase in transcription levels during the night compared to daytime (Borjigin et al., 1999). 
Interestingly, as PINA represents essentially a C-terminal half of ATP7B, it lacks all the 
cytosolic metal binding sites present in the intact protein, and TMA-TM2 helices. However, it 
retains the CPC motif which is thought to be essential for heavy metal transport (Solioz and Vulpe, 
1996), and it shows at least some copper transport activity in yeasts (Borjigin et al., 1999). 
2.3. Circadian Rhythms in Metabolism 
My research focuses on PINA, which is putatively diurnally regulated. It means, it is most 
probably involved in circadian metabolism. Circadian rhythm is a biological process that exhibit 
an endogenous entrainable oscillation which corresponds to day-night cycle. Circadian rhythms 
can be observed in organisms in all kingdoms of life. 
The rhythms are regulated by circadian clocks – internal biochemical oscillators, which 
keep running independently with a cycle of approximately 24 hours and can adjust in accordance 
to inputs from external stimuli, such as daily changes in amount of light. It is a marvellous inven-
tion of the evolution which gave a significant advantage to living organisms by making them an-
ticipate diurnal changes in the environment and hence helping them use all possible physical and 
social resources (Maronde and Stehle, 2007). 
Many biological processes follow circadian rhythms. The most significant physiological 
landmarks of the circadian cycle in mammals are melatonin levels, core body temperature 
(Benloucif et al., 2005) and cortisol levels in blood plasma. Other changes include heart rate, oxi-
dative stress, cell metabolism, immune and inflammatory responses, epigenetic modification, hy-
poxia/hyperoxia response pathways, endoplasmic reticular stress, autophagy, and regulation of the 
stem cell environment (NHLBI, 2014). 
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Interestingly, the photodetection that ultimately influences the internal clock is not con-
nected with visual perception: experiments show that even in transgenic rats which lack any func-
tional cones and rods in their retinas the light-dependent circadian entrainment and melatonin syn-
thesis still occurs (Freedman, 1999; Lucas et al., 1999). It was found (Sekaran et al., 2003) that 
retina contains a population of light-sensing neurons that transmit the information on light condi-
tions – in particular wavelength of 480 nm – downstream to the “master clock”. The “master clock” 
 
Figure 2.7: Human photoneuroendocrine system. Light information reaches suprachiasmatic nucleus (violet), 
which inhibits (red arrow) the paraventricular nucleus (yellow) during day time. Green arrows represent night 
time neuronal activity: the axons of the uninhibited paraventricular nucleus send signals to the preganglionic 
sympathetic neurons, which then transmit the signal to the superior cervical ganglia (light yellow), and the axons 
of the neurons of the latter innervate the pineal gland, which produces melatonin and releases it into blood (from 
“The Brain from Top to Bottom”, 2015) 
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which coordinates the cycle resides in the suprachiasmatic nuclei (SCN) – a part of the brain lo-
cated in the anterior hypothalamus (Ralph et al., 1990). Information on light conditions reaches 
the suprachiasmatic nuclei via the retinohypothalamic tract coming from the retina (Fig. 2.7). 
 
Suprachiasmatic nuclei send innervation to various parts of the brain; one of these path-
ways leads to the paraventricular nucleus (PVN), which, in turn, sends innervation to the pineal 
gland, a major component of circadian machinery. The suprachiasmatic nuclei receive environ-
mental light information from eyes and then inhibit the paraventricular nucleus by GABA release. 
Inhibition of the paraventricular nucleus results in decreased noradrenergic output of the superior 
cervical ganglia to the pineal gland, which leads to downregulation of N-acetyltransferase (NAT), 
a crucial enzyme for melatonin synthesis (Kalsbeek et al., 1999).  
 
Figure 2.8: Mammalian circadian master clock components. Activating effects are represented with blue arrows, 
inhibition is represented by maroon barred lines. Ccg – clock controlled genes. Casein kinase 1δ (CK1δ) and 
casein kinase 1ε (CK1ε) are important factors that regulate core clock proteins turnover (from Ko and Takahashi, 
2006). Reprinted by permission of Oxford University Press. 
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Interestingly, although all these structures lie in close proximity in the brain, the nervous 
path from the paraventricular nucleus to the pineal gland is somewhat convoluted: it goes down to 
the spinal cord to the preganglion sympathetic neurons, and then back up to the superior cervical 
ganglia, and the neurons of the latter finally innervate the pineal gland (Fig. 2.7). 
Molecular mechanism of the circadian clock, in particular, the regulation of “master clock” 
genes is known. The master clock itself self-regulates in a ~24 hour fashion via a network of feed-
back loops. The cells of the suprachiasmatic nuclei have a cell autonomous system of timekeeping, 
which consists of several genes and their products: CLOCK, BMAL1, PER and CRY (Fig. 2.8). 
CLOCK and BMAL1 comprise the positive component of the feedback loop and induce Period 
and Cryptochrome genes (Gekakis et al., 1998). They upregulate PER:CRY and REV-ERBα, 
which act as negative component of the feedback loop and suppress CLOCK:BMAL1 (Kume et 
al., 1999; Okamura et al., 1999; Guillaumond et al., 2005). CLOCK:BMAL1 also serves as an 
effector for clock-dependent genes. Examples of clock dependent (cyclically regulated) genes in-
clude Mug2 (a protease inhibitor), Ccr4 (chemokine receptor 4); Dtx4 (a Notch pathway E3 ubiq-
uitin ligase), Atp4a (α-subunit of gastric H/K-ATPase), and many others (Storch et al., 2002; Zhang 
et al., 2014). In fact, it was found that at least 43% of all mouse gene-coding mRNAs exhibited 
diurnal variability (Zhang et al., 2014). Such large-scale cyclical changes are also known in plants 
and unicellular organisms (Liu et al., 1995; Michael and McClung, 2003). So, not only the core 
clock components depend on circadian rhythm, but also other clock-controlled genes (CCGs). This 
indicates the high importance of cyclic regulation in proper functioning of a multicellular organ-
ism. Importantly, the “master clock” is responsible for cyclical signalling from SCN to PVN, which 
in turn controls the pineal gland function. 
2.4. Pineal Gland and Melatonin 
Pineal gland, or epiphysis, is a small neuroendocrine structure in vertebrate brain, which 
plays one of central roles in circadian system. Evolutionarily, it appeared along with lateral eyes, 
which became sensors for visual information, and took the role of sensing the changes of light and 
darkness and transform this information into hormonal signals (Peirson and Foster, 2006). In lower 
vertebrates, the pineal gland performs the light sensing directly, being a so-called “third eye” 
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(Mano and Fukada, 2006). In higher vertebrate, however, the evolution deprived the pineal gland 
of its light-sensing role by internalizing it into the brain. Pinealocytes of higher vertebrates under-
went certain evolutionary changes as well, for example, they lost their internal clock function 
(Okano and Fukada, 2001; Mano and Fukada, 2006). 
 
Still, they have a considerable resemblance to photoreceptor cells: they even retain photo-
sensory proteins of unknown function, possibly vestiges of evolution. Thus, in mammals, the pin-
eal gland now only transduces the environmental light information coming from the suprachias-
matic nuclei into hormonal signals. Despite the fact that the pineal gland and pinealocytes under-
went serious morphological changes over the course of evolution, the gland’s function as a mela-
tonin-producing body remained (Maronde and Stehle, 2007). 
In animals, melatonin (Fig. 2.9) is a hormone involved in circadian rhythm regulation 
(Hardeland et al., 2006). It is predominantly produced in the pineal gland, but also in retina, where 
it acts locally (Tosini and Fukuhara, 2003). The effects of the melatonin are carried out via mela-
tonin receptors, which are found in the suprachiasmatic nuclei and pituitary gland, and also in the 
retinal cells. There are also reports of melatonin receptors present in gonads (Morgan et al., 1994). 
So mainly the effects of melatonin are executed locally in the central nervous system, where mel-
atonin helps to entrain the circadian clock in the suprachiasmatic nuclei and regulate physiological 
processes in the body and behaviour via the action of pituitary gland. 
 
Figure 2.9: Melatonin molecule 
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Melatonin is synthesized in a short biochemical pathway from serotonin by the consecutive 
action of two enzymes: NAT (serotonin N-acetyltransferase) and HIOMT (acetylserotonin O-me-
thyltransferase) – which are pineal-specific (Axelrod and Wurtman, 1968). HIOMT is a rate-lim-
iting enzyme in the biosynthesis of melatonin (Reiter et al., 2007). The expression of NAT and 
HIOMT genes is controlled by pineal regulatory element (PIRE) sequences – conserved TAAT/C 
sequences in the promotors of the pineal-specific genes, which bind CRX (cone-rod homeobox) 
(Li et al., 1998). CRX is a photoreceptor-specific transcription factor (Furukawa et al., 1997) 
which is believed to transactivate photoreceptor-specific genes and regulate photoreceptor differ-
entiation. In pineal gland, it is present at all times, but the level shows diurnal pattern, with the 
peak of expression 1-2 hours before the peak of NAT (Li et al., 1998). In the research done by 
Borjigin and colleagues (Borjigin et al., 1999), the PINA gene has been shown to have the PIRE 
regulatory sequence in its promoter, like NAT and HIOMT. Spatial distribution of transcription of 
both NAT and PINA mRNAs follows that of CRX exactly in the pineal gland and retina. While it 
seems that CRX is involved in upregulation of both melatonin synthesis pathway genes and PINA, 
the regulation is more complex and involves additional factors. Such factors, which regulates mel-
atonin synthesis pathway genes, are CREB/ICER (CRE-binding protein and inducible cAMP early 
repressor). They are involved in clock genes and CCGs regulation in pineal gland and other tissues 
(Foulkes et al., 1996; Zmrzljak et al., 2013), and play important role in brain plasticity (Borlikova 
and Endo, 2009). In the pineal gland, CREB/ICER connect incoming ambient lighting information 
in form of norepinephrinergic cAMP response to the clock-controlled genes expression. Synergy 
of CRX and CREB/ICER is the likely mechanism that ensures both tissue specificity and diurnal 
behaviour of expression of melatonin pathway genes. It is possible that PINA transcription is reg-
ulated by both CRX and CREB/ICER in the same way. 
2.5. PINA – Putative Copper Transporter from Pineal Gland 
Studies of the mechanism of control of expression of NAT and HIOMT led to a discovery 
of the PIRE elements described above, as well as a novel transcript, which was regulated by the 
same mechanism. The novel mRNA was characterized as a splice variant of ATP7B, and its tran-
scription had the same temporal behavior as that of NAT. The splice variant was designated PINA 
(pineal night-specific ATPase) (Borjigin et al., 1999). 
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Two variants of PINA mRNA were detected, which differed by their polyadenylation tails. 
Both mRNAs have a pineal-specific 300 bp 5’-UTR. It is located in the intron region of the ATP7B 
gene just upstream the exon 9. 
PINA expression in the pineal gland was shown to be regulated both developmentally and 
diurnally. In adult rats, PINA mRNA is detected only in the pineal gland and, to a lesser extent, in 
the retina. Its transcription pattern follows that of the NAT mRNA: it is undetectable in light period, 
first appears 3 hours into the dark period, peaks after 6 hours into the dark period, and abruptly 
disappears within 1 hour after the beginning of the light period (Borjigin et al., 1999). Both genes 
follow a different pattern in neonatal rats: in two-days old rats the mRNAs can be detected both at 
daytime and nighttime, although the diurnal variation already exists. In 16-days old rats both gene 
products become undetectable at day. In the same age, sympathetic innervation to the gland ma-
tures. Different transcriptional patterns at different developmental stages indicate that PINA may 
play some role in the photoreceptor and photoreceptor-like cell lines development. According to 
the experiments, both PINA and NAT are regulated by circadian clock via the β-adrenergic recep-
tors and cAMP intracellular signalling (Borjigin et al., 1999). 
According to its sequence (GenBank accession number: AF120492), PINA mRNA encodes 
the C-terminal half of the ATP7B (Fig. 2.10). The predicted polypeptide sequence is missing the 
metal binding domains, as well as the first four transmembrane helices. 
Rat PINA has complete N- and P-domains required for ATP hydrolysis as well as copper-
binding sites in the transmembrane domain. A-domain retains the conserved TGEK motif, but it is 
unclear whether A-domain is functional, because due to absence of TM2 it is attached to the M-
domain with only one linker instead of two in the full-length protein. The retention of essential 
components of the enzyme needed for ion transport and ATP hydrolysis suggests that PINA could 
have ATPase and copper-transport activity. Indeed, the rat PINA protein was shown to rescue the 
phenotype in yeast deficient in the endogenous Cu+-ATPase (Borjigin et al., 1999), although to a 
lesser extent than complete ATP7A used as a control. 
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Synchronous transcription of PINA and melatonin synthesis-related genes, such as NAT, 
may indicate that the PINA protein is important either for the functioning of the melatonin synthe-
sis pathway, or that it is needed elsewhere for the circadian-regulated “cell maintenance” proce-
dures. 
Interestingly, a public mRNA database contains a corresponding entry for human ATP7B 
splice variant, ATP7B.K (Totoki et al., 2005; “AceView”, 2015; GenBank accession number: 
AB209461), which was encountered in brain tissue during human genome sequencing. This se-
quence is remarkably similar to rat PINA: it represents a truncation of human ATP7B at the Met 
residue (M796) homologous to that of rat ATP7B (M788). There is, however, a significant differ-
ence as well: the predicted protein lacks 18 amino acid residues at the border of TM3 (ATP7B 
nomenclature) and the nascent extracellular loop (Fig. 2.10 and Fig. 2.11). 
 
A glimpse on a possible structure of such an unusual protein can be made using a known 
crystal structure of the “parent” protein, ATP7B, described above. The model (Fig. 2.11) shows a 
construct truncated at M796, with the deletion region highlighted with green colour. Most features 
of the putative human PINA protein – such as retained essential components of the copper trans-
duction pathway (CPC and YN/MS motifs) in the transmembrane segment, intact cytoplasmic do-
mains and C-terminus – indicate a strong possibility that this protein can indeed be a functional 
copper transporting ATPase with novel regulation properties (A-domain attached only with one 
 
Figure 2.10: Schematic view of domain composition of ATP7B. Red arrow indicates the beginning of the puta-
tive PINA protein. Green line denotes the deletion of 18 a.a. in ATP7B.K 
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linker, missing S-domain, missing MBDs, preserved C-terminal tail). The question is whether the 
features of the protein really make it a specially-regulated copper pump important in diurnal me-
tabolism. 
 
Our hypothesis is that PINA – a novel splice variant of ATP7B – is present in pinealocytes 
and is involved in circadian regulation of copper metabolism in the brain. 
 
Figure 2.11: Model of putative PINA homologue from human, corresponding to Δ1-795ATP7B. Yellow – A-do-
main, cyan – ATP-binding domain (P- and N-domains), red – transmembrane domain, green – deletion in 
ATP7B.K (model is based on homology model from Schushan et al., 2012). 
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3. Materials and Methods 
3.1. Molecular Biology Methods and Strain Description 
Plasmid preparation. 
Single colonies were selected on LB-ampicillin plates, inoculated into 5 mL of liquid LB-
ampicillin medium, and grown for 16 hours at 37°C with shaking at 220 r.p.m. Plasmids were 
isolated using Mini-Prep kits (Qiagen, Burlington, ON) and suspended in sterile double distilled 
water. Plasmids were stored at -20°C. 
Restriction digestion. 
All restriction enzymes were purchased from ThermoFisher Scientific (Waltham, MA). 
DNA restrictions were set up in 20 µL volumes with 0.5 – 2.0 µg of plasmid DNA, 0.5-1 µL of 
each restriction enzyme, 2 µL of appropriate 10x NEB reaction buffer. Restriction digestions were 
incubated at 37°C for 90 minutes. 
Ligation Reactions 
Ligation reactions were set up in 20 µL volumes. Each reaction contained vector DNA and 
the insert DNA at a ratio of 1:3, 2 µL of 10x T4 DNA ligase buffer, and 0.5 U of T4 DNA ligase 
(New England Biolabs, Ipswich, MA). Ligation mixtures were incubated for 16 hours at 16°C. 
E. coli transformations. 
Chemically competent E. coli cells were prepared using CaCl2, essentially as described 
previously (Dagert and Ehlrich, 1979). Competent cells (50 µL) were incubated with 0.5 µg plas-
mid DNA on ice, for 45 minutes. The cells were then heat shocked for 45 seconds at 42°C, incu-
bated on ice for 10 minutes, and then transferred into 1 ml of LB broth and incubated at 37°C for 
1 hour with gentle shaking. After the 1 hour growth the cells were plated on LB-ampicillin agar 
plates and incubated for 16 hours at 37°C. 
Description of strains used in cloning and expression 
E. coli DH5α 
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The Escherichia coli DH5α strain is commercially available (Invitrogen, Burlington ON) 
and is ideal for cloning and storage of plasmids because of its ability to take up and retain plasmid 
DNA. DH5a cells have the genotype: F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 
hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1. 
E. coli BL21(DE3) 
BL21(DE3) strain is commercially available (New England Biolabs, Ipswich MA) and is 
ideal for overexpression of recombinat proteins because it contains DE3, a λ prophage carrying a 
gene of T7 polymerase. T7 polymerase expression is driven by lac promoter (IPTG is used as an 
inducer). Vector expression is driven by a strong T7 promoter, and is suppressed until induction 
by IPTG. The genotype is fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS; λ DE3 = λ sBamHIo 
∆EcoRI-B int::(lacI::PlacUV5::T7gene1) i21 ∆nin5 
K. lactis YCT-284 
The Kluyveromyces lactis YCT-284 yeast strain is commercially available (New England 
Biolabs, Ipswich MA) and is easy to use high productivity eukaryotic expression system. It has a 
number of advantages over other yeast and bacterial systems: it’s a safe strain used in food industry 
and capable of quickly reaching high cell density and recombinant protein production, the expres-
sion is driven by a strong LAC4 promoter with no background expression in E. coli, and antibiotic-
free selection method that uses amdS gene in the transformation vector that allows cells to utilize 
acetamide as a sole source of carbon. The YCT-284 cells have genotype: haploid, matα, ∆cts1. 
3.2. Plasmid Construction and Description 
The base plasmid used for cloning and expression of ATP7B and its variants was the 
pKLAC2 plasmid (New England Biolabs, Ipswich MA; Fig. 3.1), which is designed to have both 
yeast and bacterial origins of replication. 
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Plasmid pKLAC2-ATP7B (Fig. 3.2) was constructed previously by Dr. Nataliya Dolgova, 
Dmitriev lab. To produce truncated derivatives of ATP7B, the pcDNA3.1-WNDPGly875/HindIII-vec-
tor (containing ATP7B cDNA, prepared by Dr. Nataliya Dolgova, Dmitriev lab) was used as a 
template to produce DNA sequence encoding His-tagged protein Δ1-795ATP7B (Fig. 3.3). The se-
quence was produced using PCR with matching primers, with forward primers starting at Met796 
having Met+6xHis addition and HindIII restriction site (DT-PINAaF), and the reverse primer hav-
ing NotI restriction site (DT-7BR). This DNA sequence was cloned into pKLAC2 plasmid using 
 
Figure 3.1: pKLAC2 (9107 bp) contains the 5´ and 3´ ends of the LAC4 promoter (PLAC4-PBI) separated by DNA 
encoding β-lactamase (ApR) and the pMB1 origin (ori) to allow for its propagation in E. coli. The K. lactis α-
mating factor secretion leader sequence (α-MF), multiple cloning site (MCS), and the LAC4 transcription ter-
minator (TT) lie immediately downstream of 3´ PLAC4-PBI. The yeast ADH1 promoter (PADH1) drives expression 
of an acetamidase selectable marker gene (amdS). The vector can be linearized by digestion with SacII or BstXI 
to create a linear DNA fragment capable of inserting into the native LAC4 promoter region of the K. lactis 
genome.  
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HindIII and NotI restriction sites. Cloning with these sites is necessary to remove α-mating secre-
tion sequence from pKLAC2 plasmid, so the proteins of interest would integrate into the intracel-
lular compartments and not secreted from yeast cells. Automated DNA sequencing was used to 
verify the construct. 
 
Construct for cloning and expression of ATP7B.K (Fig. 3.3) was produced by deleting a 
sequence of 54 bp encoding 18 amino acids that are not present in ATP7B.K versus the corre-
sponding part of human ATP7B by around-the-plasmid PCR of pKLAC2-Δ1-795ATP7B and blunt-
end self-ligation of the product. The resulting vector was checked using restriction analysis and 
automated DNA sequencing to verify correct deletion. 
Cloning of all the vectors was done in E. coli DH5α, and plasmids were isolated from liquid 
cultures using a Miniprep DNA extraction kit (Qiagen). 
 
Figure 3.2: Map of pKLAC2-ATP7B vector. ATP7B gene is in turquoise, acetamidase in green, bacterial ampi-
cillin resisitance is in orange. ADH1 yeast promoter and parts of LAC4 promoter are in purple, yeast transcription 
terminator is in red-black colours. SacII restriction sites for linearization are indicated. 
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Table 3.1: Table of primers used in generation of plasmids 
Primer name Sequence 
DT-PINAaF 5'-TTTAAGCTTATGCATCATCATCATCATCAT 
ATGTCTCTCCAAGCCACAGAAGCCACCGTT 
DT-7BR 5'-ATCCGCGGCCGCTCAGATGTACTGCTCCT 
CAT 
DT3to4-F 5'-AACCCCAACAAGCACATCTCC 
DT3to4-R 5'-CACCAACGTCAAAGTTGACATG 
 
 
Figure 3.3: Map of pKLAC2-Δ1-795ATP7B and pKLAC2-ATP7B.K vectors. Δ1-795ATP7B/ATP7B.K gene is in 
turquoise, acetamidase in green, bacterial ampicillin resistance is in orange. ADH1 yeast promoter and parts of 
LAC4 promoter are in purple, yeast transcription terminator is in red-black colours. Magenta segment indicates 
fragment missing in pKLAC2-ATP7B.K SacII restriction sites for linearization, HindIII and NotI cloning sites 
are indicated. 
30 
3.3. Protein Expression and Purification 
3.3.1. Transformation and Expression in K. lactis 
The K. lactis cells were transformed using lithium acetate method (Gietz and Woods, 2001, 
with modifications): yeast cells were grown in YPD medium (10% yeast extract, 20% bacto-pep-
tone, 2% glucose) to OD600 of 0.6 – 1.0 (10 mL per transformation), washed in 0.5 volumes of 
wash buffer (1 M sorbitol, 10 mM Bicine-NaOH pH 8.35, 3% ethylene glycol (v/v), 5% DMSO 
(v/v)), suspended in 0.02 volumes of the same solution, and aliquots of 200 µL were frozen at -
80°C for storage. Later, cells were thawed on ice, spun down for 2 minutes at 3000 g with super-
natant removal. A total of 360 µL of the transformation mixture (25% PEG-4000 (w/v), 100 mM 
lithium acetate, 2.5 mg of boiled and ice-chilled salmon sperm DNA, 25 – 40 µg of vector DNA 
digested with SacII to produce a recombination cassette) was added to the cells and mixed gently. 
The whole mixture was kept for 30 minutes at 42°C with shaking (700 r.p.m.). Then the cells were 
pelleted by centrifugation, resuspended in 0.35 ml of water and plated on an YCB-acetamide plate. 
Colonies were re-streaked on a fresh YCB-acetamide  (yeast carbon base mix from New England 
Biolabs contains all required nutrients except a nitrogen source, 0.5 mM acetamide, 1.4% agar) 
plate and tested for expression. 
Transformed yeasts were transferred from the acetamide plate into YPGal medium (10% 
yeast extract, 20% bacto-peptone, 2% galactose), where galactose would induce expression by 
inducing LAC4 promoter. Initially, small-scale cultures of several clones of each strain were ex-
pressed to find the best timeline and the best clones. 
3.3.2. K. lactis Culture Growth and Protein Expression 
Strains of K. lactis expressing proteins of interest were grown in liquid YPGal medium 
(1% yeast extract, 2% peptone, 2% galactose) at 30°C with 220 rpm shaking for 72 hours (final 
OD600 recorded was 60-80). Then, the cells were pelleted at 3500 g for 10 minutes and resuspended 
at 4°C in deionized water (water volume equal to the initial culture volume), and pelleted by cen-
trifugation at 3500 g. Whole cell samples were disrupted with glass beads for 5 minutes in GBD-
buffer (20 mM Tris-HCl pH 7.9, 10 mM MgCl2, 1 mM EDTA, 5% glycerol, 1 mM DTT, 0.3 mM 
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(NH4)2SO4; protease inhibitors cocktail), and analyzed by SDS-PAGE and Western blot to deter-
mine the level of protein expression. 
3.3.3. Isolation of Membrane Fractions from K. Lactis Cells 
The TG-200 buffer (10% glycerol, 50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 5 mM MgCl2) 
was used for all subsequent purification steps, which were performed at +4°C. The cell pellets 
were suspended in TG-200 buffer with 1 mM DTT and Roche ULTRA protease inhibitors (as 
recommended by manufacturer) at 0.2-0.25 g wet weight per mL, and homogenized using Potter 
glass-Teflon homogenizer with subsequent disruption in cell disruptor at 39,000 p.s.i. (pounds per 
square inch). The resulting homogenate was fractionated by successive centrifugation steps at 1000 
g for 10 min and 120,000 g for 60 min. Supernatants and pellets were analyzed using western blot 
to determine fractions containing proteins of interest. 
The crude membrane fraction (120,000 g pellet) was suspended in a small amount of the 
TG-200, frozen in liquid nitrogen and stored at -80°C. For ATP7B purification, sucrose gradient 
fractionation of the membranes was used to achieve better purity. 
Crude membranes were separated on a stepwise sucrose gradient (65%, 50%, 35%, 18% 
w/v in 20 mM HEPES pH 7.5, 1 mM DTT) at 200000 g for 2 hours. Membrane fraction enriched 
in ATP7B, was collected from the 35%-50% interface, pelleted again at 200,000 g for 1 hour in 20 
mM HEPES pH 7.5, 1 mM DTT, suspended in a small amount  (2–3 ml) of TG-200, frozen in 
liquid nitrogen and stored at -80°C. 
3.3.4. Affinity Purification of ATP7B and its Variants on Ni-NTA Agarose 
Purification of His-tagged ATP7B and its variants requires extraction of the protein from 
lipids by means of solubilisation in detergent. To solubilize ATP7B, the 35-50% membrane frac-
tion was resuspended in TG-200 with 1 mM DTT, protease inhibitors cocktail and 1% LMPG 
(final protein concentration 2 mg/ml) for 30 minutes on ice, insoluble components were removed 
by centrifugation at 120,000 g for 1 hour, ATP7B.K was extracted from the crude membranes, 
instead of 35%-50% fraction, using the same protocol. 
32 
Ni-NTA agarose resin (Qiagen, Missisauga, ON) was washed with 5 column volumes (CV) 
of double distilled water and by 10 CV of the TG-200 buffer before the protein-detergent mixture 
was applied. The protein-detergent mixture was incubated with the Ni-NTA agarose (0.083 mL of 
Ni-NTA agarose beads per mg of total protein) with gentle agitation at 4°C for 30-40 minutes and 
then loaded into a chromatographic column. The column was eluted at the gravity flow.  
The column was washed with 20 column volumes of the TG-500 buffer (10% glycerol, 50 
mM Tris-HCl, pH 7.5, 500 mM NaCl, 5 mM MgCl2) supplemented with 1 mM DTT, protease 
inhibitors cocktail, 0.1% LMPG and 20 mM imidazole. The protein was eluted with 5 column 
volumes of the TG-500 buffer, pH 8.5, supplemented with 1 mM DTT, protease inhibitors cocktail, 
0.1% LMPG, and 150 mM imidazole for ATP7B, or 1 mM DTT, protease inhibitors cocktail, 0.2% 
LMPG, and 80 mM imidazole for ATP7B.K and Δ1-795ATP7B. Fractions were analyzed using SDS-
PAGE with subsequent Coomassie staining. Fractions containing the purified protein were pooled, 
concentrated by centrifugation in VivaSpin concentrator (Satorius, Göttingen, Germany) with mo-
lecular weight cut-off of 50 kDa (ATP7B) or 30 kDa (ATP7B.K and Δ1-795ATP7B) and stored in 
liquid nitrogen. 
3.3.5. Size Exclusion Chromatography 
Size exclusion chromatography was performed using ÄKTA FPLC system (GE Healthcare, 
Mississauga, ON). Superose 6 10/300 GL column (GE Healthcare, Mississauga, ON) was equili-
brated with 1 column volume of TG-500 buffer supplemented with 0.1% (for ATP7B) or 0.2% (for 
ATP7B.K and Δ1-795ATP7B) LMPG, protease inhibitors cocktail and 1 mM DTT. The protein sam-
ple was eluted with 1 column volume of the same buffer, 1 ml per fraction. 
Fractions were analyzed using SDS-PAGE with subsequent Coomassie staining. Fractions 
containing the purified protein were pooled, concentrated by centrifugation in VivaSpin concen-
trator (Satorius, Göttingen, Germany) with molecular weight cut-off of 50 kDa (ATP7B) or 30 kDa 
(ATP7B.K and Δ1-795ATP7B) and stored in liquid nitrogen. 
A small aliquot of purified protein (20 µl) was analyzed for protein concentration and purity 
by SDS-PAGE in 3.5%-20% polyacrylamide gels (Laemmli, 1970) and subsequent SYPRO Ruby 
33 
staining (see below). Purity of the proteins was calculated in SYPRO Ruby stained gels by densi-
tometry using ImageJ software (NIH), version 1.49v. 
3.4. Proteoliposomes Preparation 
To make pre-formed asolectin liposomes, 50 mg of dry asolectin (Sigma Technologies) 
was dissolved in 5 ml of chloroform. The chloroform was then evaporated under a stream of argon 
and the lipid was dried overnight in a desiccator under vacuum. Asolectin was then dissolved at 
25 mg/ml in HEPES buffer (10 mM HEPES pH 7.5, 150 mM NaCl, 1 mM DTT, 1.5% octylgly-
coside) with stirring. The asolectin suspension was then dialysed against 500 mL the same buffer 
without octylglucoside twice at +4°C for 4 hours and then overnight using a 12,000-14,000 Da 
molecular weight cut-off SpectraPor dialysis tubing (Spectrum Laboratories Inc., Rancho 
Domingeuz, California). The pre-formed liposomes were stored in liquid nitrogen until used. 
For protein reconstitution, the pre-formed liposomes were thawed on ice, extruded using 
Avanti Mini-Extruder (Avanti, Alabaster, AL) with Whatman polycarbonate membrane (Ge 
Healthcare, Piscataway, NJ) with 400 nm pore size to ensure uniform size distribution. LMPG was 
added to the extruded liposomes at a final concentration of 0.02%. After 1 hour incubation on ice, 
purified protein was added to the liposomes at the protein to lipid ratio of 1:100 w/w, and the 
liposomes were incubated for 15 min on ice. The mixture was then treated with Bio-Beads (Bio-
Rad, Hercules, CA) to remove the detergent. The Bio-Beads were changed three times, each incu-
bation was done for 18 minutes. Then, the proteoliosomes were pelleted down at 150,000 g for 1 
hour at 4°C, suspended in MES-AT buffer (50 mM MES, pH 6.0, 10% glycerol, 150 mM NaCl, 3 
mM MgCl2, 1 mM ascorbic acid, 0.1 mM TCEP) for activity assays (see below) and stored in 
liquid nitrogen for up to 3 days. Before use, thawed proteoliposomes were again extruded as de-
scribed above. 
3.5. Activity Assays 
Malachite Green Inorganic Phosphate Detection Assay 
To measure ATPase activity of ATP7B and its variants we chose a method of detection of 
liberated inorganic phosphate, a malachite green assay. It is the most sensitive colourimetric 
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method available (Lanzetta et al., 1979). We used an improved malachite green mixture formula-
tion employing polyvinyl alcohol that has been described previously (Singh and Shukla, 2003). 
The following base buffer (MES buffer) was used: 50 mM MES, pH 6.0, 10% glycerol, 
150 mM NaCl, 3 mM MgCl2. To remove heavy metal ions and Cu
2+, the buffer was treated with 
Chelex 100 resin (BioRad, Hercules, CA) prior to addition of MgCl2 as recommended by the man-
ufacturer. 
The reaction mixture was composed of MES buffer with 1 mM ascorbate, 0.1 mM TCEP, 
5 µM CuCl, 5 µM ATOX1 and varying amounts of ATP7B or ATP7B.K either in detergent or 
reconstituted into asolectin proteoliposomes. Prior to addition of (proteo)liposomes and ATP to the 
mixture, buffer containing copper, ATOX1-copper or ATOX1 was pre-incubated for 30 min at 
room temperature to reduce all oxidized copper and ATOX1, and to allow complete binding of 
copper to ATOX1. Two types of measurements with malachite green were done: single time point 
and a time course. 
When conducting single time point experiment, the whole reaction mix was dispensed in 
equal amounts (total of 40 µL) into wells of 96-well plate, and the plate was incubated for 20 or 
30 minutes at 37°C with shaking. In the end of reaction, four reaction mix volumes (160 µL) of 
malachite green mix was added to the plate, and OD630 was read out on Spectra Max M2 spectro-
photometer (Molecular Devices, Sunnyvale, CA). 
For the time course, the whole reaction mix was incubated in an Eppendorf tube at 37°C 
with shaking, and equal amounts of it were taken out every 3, 10 or 20 minutes and mixed with 1 
M EDTA solution (final EDTA concentration 125 mM) to stop the reaction by chelating Mg2+ ions. 
In the end of reaction, four reaction mix volumes (160 µL) of malachite green mix was added to 
the plate, and OD630 was read out. 
Statistical analysis of the results has been carried out with GraphPad Prism v.5 using Stu-
dent t-test. 
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Copper Transport Measurements Using Fluorescent Probe 
Copper transport activity was measured using a highly selective synthetic fluorescent sen-
sor CS-1. Uncharged copper-free CS-1 can freely diffuse across the lipid bilayer into the prote-
oliposomes. Prior to the start of reaction, all copper in the solution is bound to ATOX1, and is not 
detected by CS-1. Upon addition of ATP, copper ATPase accepts copper from ATOX1 and trans-
ports it across the liposome membrane. Inside, copper ions bind to CS-1, producing a fluorescent 
complex, which is detected with fluorescence spectrometer. The complex of CS-1-with copper is 
charged and cannot cross the membrane. Therefore as copper is transported inside the proteolipo-
some lumen, CS-1-Cu concentration inside increases, resulting in the increased fluorescence.  
The reaction was carried out in 1 mL quartz glass cuvette. Reaction medium contained 
MES buffer (pH 6.0, 50 mM MES, 150 mM NaCl, 5% glycerol, 3 mM MgCl2) with 1 mM ascor-
bate, 0.1 mM TCEP, 5 µM CuCl, 5-7.5 µM ATOX1 and 0.2-1 µM CS-1. A total of 230 µg of 
liposomes or proteoliposomes by lipid content was added. Prior to addition of (proteo)liposomes 
and ATP to the mixture, buffer containing copper, ATOX1-copper or ATOX1 was pre-incubated 
for 30 min at room temperature to reduce all oxidized copper and ATOX1, and to allow complete 
binding of copper to ATOX1. Copper transport reaction was started by addition of 1 mM ATP 
(final concentration). The measurements were performed using a Perkin-Elmer LS55 fluorescent 
spectrophotometer with emission at 556 nm and excitation at 540 nm. 
3.6. Immunofluorescence and Microscopy 
The 18x18 mm microscopic slides (VWR, Radnor, PA) were incubated in poly-L-lysine 
for 1 hour at room temperature, rinsed with PBS and double distilled water, and left to dry. Yeast 
cells expressing ATP7B and ATP7B.K grown in YPGal medium with or without added 1 mM 
CuCl2 were collected by centrifugation at 3500 g, resuspended in double distilled water and cen-
trifuged again. The collected cells were fixed in paraformaldehyde (final concentration 0.9%) for 
15 minutes with shaking at 4ºC. After that, the cells were washed with 1 M sorbitol, 50 mM 
HEPES, pH 7.5, twice. A 20 µL aliquot of yeast pellet was dissolved in 100 µl of the same buffer 
with 2 mg/ml Lyticase (Sigma-Aldrich, Oakville, ON) added, and incubated for 1 hour at 30ºC. 
Then the cells were collected by centrifugation at 2000 g, washed with 0.5 ml of 50 mM HEPES, 
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1 M sorbitol, pH 7.5, centrifuged again, resuspended in the same buffer with 0.1% Triton added, 
and incubated for 10 minutes on ice. Then 20 µL of the cell suspension was applied to the dry 
poly-L-lysine coated slides and dried under a gentle stream of air. 
These dried samples were rinsed with PBS and blocked with 5% BSA in PBS, and stained 
with antibodies against either the His-tag or N-terminus of ATP7B. 
Mouse Anti-His antibody (AM1010a from Abgent, San Diego, CA) in 1:200 dilution in 
2% BSA in PBS was applied for 1 hour at room temperature. After that the slide was washed in 
PBS, and the secondary antibodies anti-rabbit-Texas Red conjugate (Santa Cruz Biotechnology, 
Dallas, TX) in dilution 1:250, were applied for 1 hour at room temperature in the dark, and left to 
dry. 
Rat anti-ATP7B (a gift from Svetlana Lutsenko, John Hopkins University, Baltimore, MD) 
in 1:500 dilution in 2% BSA in PBS were applied for 1 hour at room temperature. Secondary 
antibodies rabbit anti-rat-GFP conjugate IgG (Rockland Immunochemicals, Limerick, PA) in di-
lution 1:500, for the anti-ATP7B were applied for 1 hour at room temperature in the dark, and left 
to dry. 
Dried slides were mounted onto microscope slides using Fluoroshield liquid mounting me-
dium with DAPI (Sigma-Aldrich, Oakville, ON), and left to dry again for 48 hours in the dark. 
The samples were imaged on a Leica SPS5 confocal microscope using 488 nm excitation 
for GFP, 595 nm for Texas Red, and 360 nm for DAPI. 
3.7. Rat Tissue Processing 
Healthy, untreated Sprague-Dawley rats were used to investigate temporal expression pat-
tern of PINA. Adult rats were housed in UCACS facility at 12:12 light cycle. Animals were given 
7 days to adapt to the new light cycle conditions. 
This series of experiments involved keeping animals at 7 PM – 7 AM night cycle, and 
sampling was performed at 10 AM, 4 PM, 10 PM and 4 AM, two samples per time point. 
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Pineal gland tissue (~4 mg) was homogenized in tissue lysis buffer (0.25 M sucrose, 20 
mM Tris-HCl pH 7.5, 0.1 M NaCl, 1 mM DTT, Roche ULTRA inhibitors as recommended by 
manufacturer), 50 µL of buffer for each sample, with a plastic pestle. Liver tissue (~2 g) was ho-
mogenized in the tissue lysis buffer (10 mL) in a glass-Teflon Potter homogenizer.  Total protein 
concentration was determined by bicinchoninic acid assay. To obtain the membrane fraction, the 
homogenate was centrifuged for 10 min at 2000 g, supernatant was collected and centrifuged at 
120000 g for 60 minutes. The resulting pellet was resuspended in 50 or 100 µL of buffer. Total 
protein concentration was determined by bicinchoninic acid (BCA) assay. Tissue homogenate and 
membrane samples were analysed by SDS-PAGE and Western blot. 
3.8. Miscellaneous Methods 
SDS-PAGE 
SDS-PAGE was carried out essentially as described previously (Laemmli, 1970). The 
stacking gel layer contained 3.5% acrylamide, and the separating gel contained a linear gradient 
of 3.5% to 20% acrylamide. 
Western Blot Analysis 
Western blot analysis was carried out as previously described (Towbin et al., 1979). Protein 
was transferred to PVDF or nitrocellulose membrane by electroblotting at 350 mA for 60 minutes. 
To detect His-tagged proteins, Western blots were probed using the Qiagen monoclonal anti-pen-
tahistidine horse radish peroxidase (HRP) conjugate antibody (1:10,000 dilution) (Qiagen, Missis-
sauga, ON) according to manufacturer’s instructions. Western blots were done with either a pri-
mary polyclonal rabbit anti-ATP7B antibody H-94 (Santa Cruz Biotechnology, Dallas, TX) or pri-
mary polyclonal rabbit anti-ATP7B antibody PA2262 (Bosterbio, Pleasanton, CA). The secondary 
antibody used was goat anti-rabbit HRP conjugate antibody (TermoFisher Scientific, 1:10,000 di-
lution in PBS with 0.1 % Tween-20). 
Both anti-ATP7B antibodies were raised against the unique epitope in the C-terminal tail 
in ATP7B. The epitope used for production of the H-94 antibody: Q1372-I1465. The epitope used 
for production of the PA2262 antibody: D1450-I1465. 
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Expression and Purification of ATOX1 
ATOX1 expression and purification was done according to a protocol previously estab-
lished in our lab (Dolgova et al., 2013). In brief, E. coli BL21(DE3) transformed with the pTYB12 
vector (New England Biolabs, Ipswich, MA) encoding human ATOX1 gene (a gift from Svetlana 
Lutsenko, John Hopkins University, Baltimore, MD) was grown in LB medium for 16 hours, and 
transferred to M63 minimal medium. Expression was induced by isopropyl β-D-thiogalactoside 
(final concentration 0.5 mM), the cells were grown for 16 hours, and collected by centrifugation. 
The cells were disrupted in the cell disruptor, cell debris and membranes were removed by centrif-
ugation, and the purification was done on chitin resin, followed by size-exclusion chromatography. 
The protein concentration was quantified using Lowry assay. 
Protein Quantification 
Total protein quantification in whole cell extracts, tissue extracts, and membrane prepara-
tions was done using Pierce BCA Protein Assay Kit (ThermoFisher Scientific, Waltham, MA) per 
manufacturer’s manual. BSA standard curves ranging from 1.2 µg to 12 µg per sample were used 
with each assay. The reaction mixture was supplemented with 2% SDS (final) to release proteins 
from the membranes and improve accuracy. 
Purified proteins were quantified by in-gel staining with SYPRO Ruby fluorescent dye 
(ThermoFisher Scientific, Waltham, MA). SDS gels were stained according to manufacturer’s pro-
tocol. BSA standards ranging from 0.02 µg to 1 µg of protein per sample were included with each 
assay. Two or three sample dilutions were used to insure assay linearity. Gel images were analyzed 
using ImageJ (National Institute of Health, Bethesda, MD) and LibreOffice Calc software. 
ATOX1 concentration determination was carried out as previously described (Lowry et al., 
1951). BSA standard curves ranging from 3 µg – 60 µg per sample were conducted with each 
assay. 
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4. Results 
4.1. Expression of ATP7B and its variants in yeast Kluyveromyces lactis 
In order to obtain recombinant human ATP7B and its variants – ATP7B.K (putative PINA 
homologue from human genome) and Δ1-795ATP7B (ATP7B with its N-terminus truncated at 
M796) for activity studies, they had to be expressed in a eukaryotic organism. There are multiple 
reasons for that. First of all, ATP7B and, presumably, its shorter variants, normally reside in com-
partments of the endomembrane system, which is absent in prokaryotic cells. Protein synthesis 
machinery in prokaryotes may lack necessary components for production of eukaryotic proteins, 
such as glycosylation, methylation and other modifying enzymes, specific chaperones, trafficking 
proteins. Kluyveromyces lactis expression system from New England Biolabs is used in industrial 
production of recombinant proteins, and has a number of advantages in comparison to the other 
systems. Mammalian expression systems are expensive, and the yield of protein is quite low; the 
same cost issues also apply to insect cells. Yeast expression systems allow protein production in 
large culture volumes at high yield at comparatively low cost. In comparison to the other yeast 
species, like Pichia or Saccharomyces, Kluyveromyces lactis YCT284 offers an easy induction 
approach which involves galactose as both carbon source and inducer. 
Expression vectors encoding proteins of interest (His6-ATP7B, His6-Δ1-795ATP7B and His6-
ATP7B.K) were generated and cloned in E. coli DH5α, then transformed and expressed in K. lactis. 
Yeast cells were transformed with a linear integration cassette carrying the recombinant gene and 
amdS gene, which encodes acetamidase. Acetamidase enables the transformed cells to utilise ac-
etamide as a sole source of nitrogen when they are grown on a minimal medium for selection. 
Expression of the cloned gene is driven by a strong K. lactis LAC4 promoter, induced by growth 
on galactose-containing medium. 
Expression of ATP7B and its two truncated variants was detected in crude cell extracts with 
antibodies against C-terminus of ATP7B (Fig. 4.1). The observed slight discrepancy in the ex-
pected and actual molecular weight can be attributed to the fact that the electrophoretic mobility 
of  membrane proteins can vary due to such factors as detergent binding (Rath et al., 2008). 
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Even though mammalian membrane proteins are generally expressed and folded well in 
the yeast expression systems, we needed to check if this is also true for the ATP7B variants. Het-
erologously overexpressed membrane proteins can be misfolded, and then degraded or accumu-
lated in inclusion bodies. Folded and inserted enzymes still can be non-functional. An easy way to 
establish whether ATP7B protein is folded properly is to check its trafficking behaviour. This pro-
tein is known to be trafficked between various membrane compartments in mammalian hepato-
cytes in response to changes in copper concentration. By subjecting yeast to high and low copper 
concentrations, it should be possible to induce protein relocalization in the cells, which would 
indicate proper folding of the enzyme. It has been shown previously that ΔMBD1-5ATP7B does in-
deed relocalize in yeast after their treatment with copper (II) chloride, and the solubility of the 
protein in detergent changes as well (Portmann and Solioz, 2005). Change in solubility means that 
there is different lipid environment, which is an indication of a different membrane compartment, 
and also can be used to assess relocalization. 
 
Figure 4.1: Expression of the ATP7B variants in K. lactis detected by Western blotting. Expressed recombinant 
proteins were detected in crude cell extracts by Western blot analysis with the polyclonal Anti-ATP7B antibody 
against C-terminus (H-94, Santa Cruz Biotechnology). All cell samples were disrupted with glass beads, and 10 
µg of total protein were loaded on SDS-PAGE gels for subsequent analysis. 
A – ATP7B (calculated MW 157 kDa); B – Δ1-795ATP7B (calculated MW 71 kDa); C – ATP7B.K (calculated 
MW 69 kDa) 
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To test if ATP7B and ATP7B.K expressed in yeast change their intracellular localization in 
response to high copper concentration, the cells expressing ATP7B and ATP7B.K have been grown 
in YPGal medium with or without added CuCl2, fixed on a microscopic slide and immunostained 
with antibodies against the C-terminus of ATP7B. The results indicate that the protein responds to 
elevated copper by relocalization between different cell compartments (Fig. 4.2). 
ATP7B showed a distinctively different localization in cells grown in low and high copper 
concentrations. Without added copper, the expressed protein is localized in compact fashion in 
close proximity to nucleus – a typical pattern for TGN localization. When cells are grown at ele-
vated copper, the protein localizes mainly to the cytoplasmic membrane. 
ATP7B.K staining in yeast grown without additional copper shows a granular pattern, 
mainly in cytoplasm (Fig. 4.2, C). In the presence of high copper amounts it also tends to relocalize 
to the plasma membrane (Fig. 4.2, D). 
 
Figure 4.2: Recombinant ATP7B and ATP7B.K visualization in fixed K. lactis yeast cell by immunostaining (in 
false colours). Blue – nucleus (DAPI), green – ATP7B (anti-ATP7B, Santa Cruz), red – ATP7B.K (anti-ATP7B, 
Santa Cruz). A – ATP7B expressing yeast grown without added copper; B – ATP7B expressing yeast grown in 
1 mM CuCl2; C -  ATP7B.K expressing yeast grown without added copper; D -  ATP7B.K expressing yeast 
grown in 1 mM CuCl2 
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Movement of a protein between membrane compartments can be traced by separating the 
crude membrane fraction of a cell into sub-fractions using density gradients (Liu and Fagotto, 
2011). To see how ATP7B and ATP7B.K is distributed among various membrane fractions in cells 
grown with or without added copper, crude membranes of the cells expressing ATP7B and 
ATP7B.K grown without added copper or in presence of 1 mM CuCl2 were fractionated using 
sucrose gradient separation. 
 
Figure 4.3: Distribution of the recombinant ATP7B and ATP7B.K proteins between various membrane fractions 
of K. lactis cells grown in presence or absence of 1 mM CuCl2. Crude membrane fractions were separated on 
sucrose gradients, and 10 µg of total protein was loaded on SDS-PAGE gels for subsequent analysis. 50-65% 
fraction from cells grown in low copper concentration was not analyzed because there was no visible membrane 
material at the interface of 50% and 65% solutions. 
A – ATP7B, Coomassie stain; B – ATP7B, Western blot with anti-PentaHis antibody; C – ATP7B.K, Coomassie 
stain; D – ATP7B.K, Western blot with anti-PentaHis antibody. 
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When subjected to sucrose gradient fractionation, the crude membrane fraction of ATP7B-
expressing K. lactis grown without added copper separated into two distinct fractions: at the inter-
face of 35% and 50% sucrose solutions (major fraction), and at the interface of 18% and 35% 
solutions (minor fraction), with no visible membrane material at the interface of 50% and 65% 
solutions (Fig. 4.3, A-B). 
 
The crude membrane fraction of cells grown in the presence of 1 mM copper (II) chloride 
separated into three fractions: the aforementioned 18-35% and 35-50%, and also a heavier 50-65% 
minor fraction. This fraction most likely represents protein-loaded transport vesicles which are 
 
Figure 4.4: Solubilisation of the recombinant ATP7B protein from crude membrane fraction of K. lactis cells 
grown in presence or absence of 1 mM CuCl2. Crude membrane fractions (total protein 2 mg/ml) were solubil-
ised in various concentrations of DDM and LMPG. 
A - Coomassie stain; B - Western blot with anti-PentaHis antibody 
S – soluble fraction, P – insoluble fraction; DDM concentrations are indicated; LMPG was taken at 1% concen-
tration 
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involved in protein trafficking to the plasma membrane. This agrees with the immunofluorescence 
data (Fig. 4.2) that copper in the growth medium induces trafficking of the protein. 
Previously (Portmann and Solioz, 2005) it was shown that elevated copper concentration 
in the growth medium makes ΔMBD1-5ATP7B expressed in S. cerevisiae soluble in dodecyl malto-
side (DDM) at a total membrane protein to detergent ratio 1:1 (w/w). We have conducted solubili-
sation trial to see whether the same applies for the full-length ATP7B expressed in K. lactis (Fig. 
4.4). The experiment has shown that elevated copper concentration does not significantly change 
solubility of the full-length ATP7B from K. lactis crude membranes in either 1:1 protein-detergent 
ratio (w/w; 0.2% of DDM) or 1:2 ratio (w/w; 0.4% of DDM). 
ATP7B.K expressing yeast cells showed somewhat different protein compartmentalization. 
Membrane fraction pattern for cells grown with and without copper were similar to the cells ex-
pressing full-length ATP7B (two fractions without copper and three fractions with 1 mM CuCl2); 
however protein distribution between the fractions was different, with higher relative amount of 
ATP7B.K in 50-65% fraction (Fig. 4.3, C-D). 
Response to copper from the expressing host may serve as another indication of the recom-
binant ATP7B and variants function. To test this response, we have grown the transformed yeast 
on YPGal-agar plates supplemented with copper ranging from 0 to 5 mM. 
Background strain of K. lactis and cells expressing ATP7B.K or Δ1-795ATP7B all showed 
good growth at elevated copper levels. Because the gene of the endogenous K. lactis Cu-transport-
ing ATPase, CCC2, is present in all transformants, the similar response to copper concentration 
may be due to CCC2 activity. However, the cells expressing ATP7B showed lower viability when 
copper content in the medium exceeded 2 mM and higher (Fig. 4.5). This may be caused by ATP7B 
suppressing the expression of the yeast CCC2 and not being able to function as effectively in yeast 
cells, for example, it might be unable to load cuproenzymes such as SOD properly. The recombi-
nant ATP7B can also interfere with the endogenous copper transport pathway by not being able to 
transfer copper to yeast copper acceptors efficiently and competing for them with CCC2, under-
mining its function. Yeast cells may also lack some yet unknown effectors that would enable proper 
copper export by ATP7B from a cell, leading to excessive copper accumulation and toxicity. The 
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truncated constructs ATP7B.K or Δ1-795ATP7B expressed in K. lactis cells did not have the effect 
of the full-length enzyme on the yeast growth on high copper containing medium, which suggests 
that they do not interfere with the yeast metabolism in the same was as ATP7B does. The findings 
mentioned above suggest that the recombinant proteins, namely ATP7B, Δ1-795ATP7B and 
ATP7B.K, are not degraded and folded properly. 
 
Because the purification procedure – detergent treatment in particular – might have an ad-
verse effect on enzymes, we also conducted ATPase activity measurements in 35-50% microsomes 
from the transformed yeast to see how the proteins behave in membrane environment, and how 
they compare with the activity of subsequently purified proteins. Because the host K. lactis cells 
have their own intrinsic copper ATPase, all measurements should be compared to the background 
strain. 
 
Figure 4.5: K. lactis yeast cells grown on YPGal-agar medium at various copper concentrations. Copper concen-
tration is indicated to the left of each pair of plates; the expressed protein is indicated below each series of plates. 
WT – background strain (non-transformed). 
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The yeast expressing ATP7B showed significantly (p < 0.05) higher ATPase activity in 
their 35-50% membrane fraction than the background strain of yeast (Fig. 4.6 and Fig. 4.9). The 
activity in the membranes of ATP7B.K expressing yeast was comparable to that of ATP7B-ex-
pressing strain, also significantly (p < 0.05) higher than the background strain. This serves as an 
indication of activity of both of these constructs in vivo when expressed heterologously. The ac-
tivity in the membranes of Δ1-795ATP7B expressing yeast was not different from that of the back-
ground strain of yeast (Fig. 4.8 and 4.9), but additional copper activated the enzyme (Fig. 4.9).  
 
 
Figure 4.6: Time course of Pi production by 35-50% membrane fraction of background strain of K. lactis cells 
(BkgdS), ATP7B and ATP7B.K transformants: response to copper stimulation or BCS. The assay contained 14.3 
ng of total membrane protein per reaction. Measurements were done in triplicates. Concentrations used are: 
copper 3 µM, BCS 100 µM 
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Figure 4.7: Time course of Pi production by 35-50% membrane fraction of background strain of K. lactis cells 
(BkgdS), ATP7B and ATP7B.K transformants: response to copper-ATOX1 stimulation. The assay contained 
14.3 ng of total membrane protein per reaction. Measurements were done in triplicates. Concentrations used are: 
copper 3 µM, ATOX1 5 µM 
 
Figure 4.8: Time course of Pi production by 35-50% membrane fraction of background strain of K. lactis cells 
(BkgdS) and Δ1-795ATP7B transformants: response to copper, ATOX1-Cu stimulation or BCS. The assay con-
tained 14.3 ng of total membrane protein per reaction. Measurements were done in triplicates. Concentrations 
used are: copper 3 µM, ATOX1 5 µM, BCS 100 µM 
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In some experiments, ATOX1-Cu showed inhibiting effect on activity in the membranes of 
the background strain (Fig. 4.7), but increasing sampling size eliminated this difference (Fig. 4.9). 
The calculated specific activities with respect to total microsomal protein (Fig. 4.9) show similar 
rates for both ATP7B and ATP7B.K. However, because the amount of ATP7B in the membranes 
is usually around two times greater than the truncated constructs, the actual rate of ATPase activity 
of ATP7B.K in the membranes is probably higher than that of the full-length ATP7B. 
It is worth noting that additional copper did not further activate the full-length ATP7B, and 
100 µM BCS failed to inhibit activity in any of the membrane preparations (Fig. 4.6, fig 4.8 and 
Fig. 4.9). Other groups (Pilankatta et al., 2009) also reported that much higher concentrations of 
BCS are needed for inhibition of copper-dependent ATPase activity in the microsomes. The Kd of 
BCS for copper is 10-20 M (Rae et al., 1999), while for ATOX1 it is 10-17.4 M (Xiao and Wedd, 
2010). The affinity of the enzyme to copper should be much higher than these, because even 1 µM 
residual copper in the reaction medium has been shown to stimulate the ATPase activity (Tsvikov-
skii et al., 2002), and is the most probable reason for the lack of additional copper stimulation of 
the enzymes in our experiments. 
 
Figure 4.9: Comparison of specific ATPase activity in membranes of non-transformed yeast and yeast trans-
formed with ATP7B, Δ1-795ATP7B and ATP7B.K. Specific activity is based on total microsomal protein amount. 
BkgdS – background strain. 
Statistics include 6 (all “no effector” series), 2 (Δ1-795ATP7B/Cu and ATP7B.K/Cu series) or 3 (the rest) biolog-
ical replicates, each biological replicate contains 3 technical replicates. Standard error of the mean is indicated 
by error bars. 
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4.2. Protein Purification of ATP7B and its Variants 
Obtaining a protein of sufficient purity is essential for activity studies. Purification of mem-
brane proteins usually presents a greater challenge than that of soluble proteins, because it requires 
solubilisation of a protein of interest with an empirically chosen detergent. Some detergents can 
have detrimental effect on the enzymatic activity due to excessive delipidation and conformational 
alterations of the enzyme. It is generally more difficult to achieve high purity with membrane 
proteins than with soluble ones. 
Previous attempts to solubilize ATP7B in membranes obtained from K. lactis cell in various 
detergents (Dolgova, unpublished data) showed that only lysomyristoyl phosphatidyl glycerol 
(LMPG) and chemically similar detergents (lysopalmitoyl phosphatidyl glycerol, LPPG) were ca-
pable of complete or near-complete solubilisation of the protein. Treatment of the yeast cells with 
copper did not change the solubility properties of ATP7B from different membrane fractions (Dol-
gova, unpublished data). Immunoblots (figs. 4.3 and 4.5) demonstrated that there is no effect of 
elevated copper on ATP7B synthesis, and only slight increase in ATP7B.K synthesis. The 
ATP7B.K amount in 50-65% membrane fraction of copper-treated yeast (Fig. 4.3, panel D, lane 
50/65) per microgram of total protein fraction is greater than in other fractions, but the relative 
volume of 50-65% fraction is small in comparison with other fractions. Therefore, we concluded 
that copper treatment is not a required step for protein purification, and should not be used. 
Typically, purification of membrane proteins involves several steps, including isolation of 
a membrane fraction from the host cells, treatment of these membranes with a detergent to solu-
bilise the protein of interest, subsequent purification on affinity medium, and often a secondary 
purification step (size-exclusion chromatography or additional affinity step). Initial purification 
protocol for His6-ATP7B was developed in our lab (Dolgova and Dmitriev, unpublished data) and 
employed sorbitol-based buffer, 1% LMPG as a solubilising agent, and Ni-NTA affinity purifica-
tion. 
The purification process for ATP7B and its variants consists of several steps. First, the 
grown yeast cells are collected by pelleting at low speed. Then the cell mass is suspended in a 
buffer with protease inhibitors and disrupted in cell disruptor, and the crude membrane fraction is 
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extracted by a series of centrifugation steps. The resulting membrane fraction can be either sepa-
rated further using sucrose gradients (ATP7B) or taken as is for detergent treatment to solubilise 
the proteins of interest. The protein-detergent mixture is then subjected to Ni-NTA affinity chro-
matography, where a partially pure protein is obtained. In order to increase the purity, the protein 
is concentrated and subjected to size-exclusion chromatography. The fractions that contain larger 
amounts of the protein of interest and smaller amounts of contaminants are collected, pooled to-
gether and concentrated. 
In order to get ATP7B and its variants at sufficient purity, we have undertaken a series of 
optimization steps, which have enabled us to enhance the purity of ATP7B. This included using a 
glycerol-based buffer instead of sorbitol-based, reducing detergent treatment time, and increasing 
salt concentration and shifting elution pH to 8.5 at the stage of affinity chromatography. Both Ni-
NTA affinity chromatography and size exclusion chromatography are necessary to get protein of 
reproducible purity. Affinity purification on Ni-NTA produces the protein of 20%-30% purity (Fig. 
4.10), while the additional size-exclusion step increases the purity up to 70%-80% (Fig. 4.11). In 
addition, the size exclusion chromatography serves as imidazole removal step, eliminating need 
for buffer exchange or dialysis, which is a lengthier process. 
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Figure 4.10: Purification of ATP7B by Ni-NTA affinity chromatography of crude membrane extract. P – insol-
uble fraction; FT – column flow-through, W1-W2 – column wash fractions; 1-5 – column elution fractions. 
Orange box indicates the ATP7B protein in the elution fractions. The samples were analyzed by SDS-PAGE 
followed by Coomassie staining. 
 
Figure 4.11: Purification of Ni-NTA-purified ATP7B by size-exclusion chromatography. ST – molecular weight 
standard; 6-17 – elution fractions. Orange box indicates the ATP7B protein in the elution fractions which were 
pooled for concentrating. The samples were analyzed by SDS-PAGE followed by Coomassie staining. 
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ATP7B.K has a very different structure, so we have tested its properties with respect to 
solubilisation in various detergents to establish the most suitable candidate. Because none of the 
alternative detergents were as effective as LMPG (Fig. 4.12), this detergent was selected for further 
purification of ATP7B.K and the very similar Δ1-795ATP7B. 
Because ATP7B.K and Δ1-795ATP7B have different domain composition compared to the 
full-length ATP7B, they behave differently during purification process. First, as can be seen below 
(Fig. 4.12), ATP7B.K is somewhat less soluble in comparison to ATP7B (Fig. 4.4) even with 1% 
of LMPG. The same is valid for Δ1-795ATP7B, which, in our experience, behaves very similarly to 
ATP7B.K during expression and purification.  
 
 
Figure 4.12: Solubilisation of the recombinant ATP7B.K protein from crude membrane fraction of K. lactis cells. 
Crude membrane fractions were solubilised in various concentrations of DDM and LMPG. 
A – Coomassie stain; B – Western blot with anti-PentaHis antibody 
S – soluble fraction, P – insoluble fraction; X-100 – Triton X100; Zw – Zwittergent 3:18; SLS – sodium lauroyl 
sarkosinate; Tw20 – Tween 20; DOC – deoxycholate sodium salt; CH – CHAPS. Insoluble fractions resulter 
from treatment with deoxycholate and CHAPS are not shown 
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Ni-NTA purification of Δ1-795ATP7B (Fig. 4.13, panel A) usually yields protein of less than 
15% purity (Fig. 4.14, lane CC), while the size exclusion chromatography helps to increase the 
 
Figure 4.13: Purification of Δ1-795ATP7B by Ni-NTA affinity chromatography of crude membrane extract. P – 
insoluble fraction; S – soluble fraction; FT – column flow-through. Orange box indicates the Δ1-795ATP7B pro-
tein in the elution fractions. The samples were analyzed by SDS-PAGE followed by silver staining (panel A) and 
Western blot with anti-PentaHis HRP-conjugated antibody (Qiagen) (Panel B). 
 
Figure 4.14: Purification of Ni-NTA purified Δ1-795ATP7B by size-exclusion chromatography. 
CC – Δ1-795ATP7B concentrated after the Ni-NTA purification; CFT – concentrator flow-through; 9-19 – elution 
fractions. Orange box indicates the Δ1-795ATP7B protein in the elution fractions which are collected for concen-
tration. The samples were analyzed by SDS-PAGE followed by Coomassie staining. 
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purity up to 30%-40% (Fig. 4.14, lanes 11-14). Δ1-795ATP7B binds less tightly to the Ni-NTA aga-
rose, and therefore lower concentration of imidazole (80 mM) is needed for efficient elution. As a 
side effect this leads to lower purity of the eluted protein in comparison to ATP7B. 
 
A very similar observation can be made concerning the purification of ATP7B.K. The Ni-
NTA purification produces a protein with a very low degree of purity, as low as 6% (Fig. 4.15, 
panel A). The size-exclusion step helps to achieve purity similar to that of Δ1-795ATP7B, in the 
range of 30%-40% (Fig. 4.16). 
 
 
Figure 4.15: Purification of ATP7B.K by Ni-NTA affinity chromatography of crude membrane extract. 
P – insoluble fraction; FT – column flow-through; W1-2 – column wash fraction; 1-6 – column elution fractions. 
Orange box indicates the ATP7B.K protein in the elution fractions. The samples were analyzed by SDS-PAGE 
followed by followed by Coomassie staining (pane A) and Western blot with anti-ATP7B H-94 antibody (Santa 
Cruz Biotechnology) + anti-rabbit IgG (ThermoFisher Scientific) (Pane B). 
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In order to correctly assess specific activity of an enzyme, one has to know the exact protein 
concentration. Hence, reliability of protein quantification is of utmost importance. Our method of 
 
Figure 4.16: Purification of Ni-NTA purified ATP7B.K by size-exclusion chromatography.  
7-19 – elution fractions. Orange box indicates the ATP7B.K protein in the elution fractions which are collected 
for concentration. The samples were analyzed by SDS-PAGE followed by Coomassie staining. 
 
Figure 4.17: SYPRO Ruby stained SDS polyacrylamide gel of purified ATP7B and its variants. ST – molecular 
weight standard, quantities of BSA in micrograms and microliters of purified ATP7B are indicated below the 
corresponding lanes. Quantity standards used for ATP7B.K and Δ1-795ATP7B are not shown. 
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choice for quantification of ATP7B and its variants was in-gel staining using SYPRO Ruby fluo-
rescent dye. SYPRO Ruby is a sensitive dye with linear quantification range of over three orders 
of magnitude (Invitrogen, 2007), which shows consistent results for different protein types. By 
running a set of protein standards along with the sample, it is possible to determine the quantity of 
the protein of interest with good precision, even in the presence of contaminating proteins. 
Due to generally lower expression levels of the truncated proteins, as well as weaker biding 
to the Ni-NTA agarose, the overall yield and purity are lower than those of the full-length ATP7B.  
According to the in-gel quantification, protein yield was 0.10 – 0.15 mg of protein per 1 L 
of cell culture for ATP7B and 0.05 – 0.08 mg of protein per 1 L of cell culture for the truncated 
variants (ATP7B.K and Δ1-795ATP7B). Low yield is not unusual for membrane proteins, which are 
known to be produced in lower quantities than soluble proteins. The densitometry-based purity of 
the samples is as follows: ATP7B – 75%, Δ1-795ATP7B – 51%, and ATP7B.K – 41% (Fig. 4.17). 
4.3. ATPase Activity of the Purified ATP7B and its Truncated Variants 
ATPase activity of the three purified enzymes was assayed using the malachite green phos-
phate detection assay. It is the most sensitive colourimetric assay that can be used for the purpose 
of characterization of ATPase activity of an enzyme. The method (Baykov et al., 1987; Singh and 
Shukla, 2003) is suitable for detection of inorganic phosphate in amounts as low as 10 nmol of Pi 
per millilitre. Previous reports on the activity of purified and reconstituted ΔMBD1-5ATP7B (Port-
mann and Solioz, 2005) showed Pi production of 50-240 nmol of phosphate per mg of protein. 
Hence, this assay sensitivity was likely to be sufficient for our purposes. 
MES buffer, pH 6.0, with 3 mM MgCl2 was selected as a reaction medium, because pH 6.0 
was reported previously as more favourable for the PIB-ATPases phosphorylation by ATP (Solioz 
and Odermatt, 1995; Tsvikovskii et al., 2002). Our initial setting contained TCEP as a reducing 
agent for disulphide bonds, and ascorbic acid as a reducer of copper to ensure all copper stays in 
+1 oxidation state. To compare kinetic properties of the ATP7B and its variants, a time course 
measurement is needed. From Pi accumulation curve it is possible to establish initial rate of reac-
tion, which enables characterization of enzyme activity. But since no favourable conditions were 
known for our purified proteins, these had to be probed first with a single time point experiment. 
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The purified proteins were reconstituted into asolectin liposomes, to provide more natural envi-
ronment for the enzymes. 
 
First, we tested ATPase activity of proteins, reconstituted into asolectin liposomes, in MES 
buffer supplemented with 1 mM ascorbic acid, which would reduce all oxidized copper to Cu(I), 
and 0.1 mM TCEP, which is needed in order to reduce disulphide bonds involved in copper binding 
in the proteins. Cu(I) is a transport substrate of the enzymes, and is needed to activate ATP hydrol-
ysis coupled to copper transport. ATOX1 is known to supply ATP7B with copper, presumably 
activating it. However, specific activity in the presence of ascorbic acid and TCEP (MES-AT) was 
very low for all three proteins and was in the nanomol/min/mg range (Fig. 4.18), and was lower 
than what has been found in literature regarding the activity of ΔMBD1-5ATP7B (Portmann and 
Solioz, 2005) and ATP7B in microsomes (Pilankatta et al., 2009). ATOX1-copper seemed to have 
certain stimulating effect on the enzymes, ATP7B and Δ1-795ATP7B in particular. Due to the very 
low activity, which was on the lower edge of detection of the system, there was low signal-to-noise 
ratio, and as a consequence big scatter in data point values between repeats. As a result, no statis-
tically significant (p < 0.05) differences can be observed. 
Ascorbic acid in the presence of transition metals can have detrimental effect on lipids and 
proteins by free radical damage (Buettner and Jurkiewicz, 1996). In MES buffer without ascorbic 
 
Figure 4.18: Specific activity of ATP7B and its variants reconstituted into asolectin liposomes estimated from 
single point measurements in MES buffer with 1 mM ascorbic acid and 100 µM TCEP. All measurements were 
done in triplicates; reaction time was 20 minutes. Specific activity is based on total protein amount in the purified 
samples. 
Statistics include 3 technical replicates. Standard error of the mean is indicated by error bars. 
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acid (MES-T), we observed approximately tenfold higher specific activity than with ascorbic acid 
(Fig. 4.19). There was no stimulatory effect of ATOX1-copper on ATP7B and ATP7B.K. Higher 
signal provided less scatter, and the quality of data was better. 
 
However, statistically significant (p < 0.05) difference is observed only for the effect of 
ATOX1 on Δ1-795ATP7B: the copper chaperone shows stimulating effect, however, it still does not 
depend on copper. This effect may be because contaminating copper amounts are sufficient to 
activate Δ1-795ATP7B, and additional copper does not contribute to the reaction rate. The assay 
buffer without ascorbate appeared to be more favourable for ATP7B and its variants, so it was 
chosen for the time course measurements. 
The time course experiments compared the activity of the purified enzymes in two condi-
tions: 1) in the MES-T buffer, and 2) in the MES-T buffer with copper-loaded ATOX1. The pro-
teins activity was measured in detergent, because reconstitution into liposomes made it difficult to 
achieve protein quantity in the reaction mixture sufficient for a reproducible good signal to noise 
ratio. The observed difference in Pi accumulation curves is very small, which supports the idea 
that residual copper in the buffer is sufficient to activate the enzymes (Fig. 4.20). ATOX1-Cu 
showed a slight inhibition trend on ATP7B and ATP7B.K. There’s a discrepancy with the single 
time point measurement in case of the Δ1-795ATP7B: ATOX1 did not activate the enzyme. This 
may be because additional copper exhibited an inhibitory effect on enzyme. Similar behaviour was 
 
Figure 4.19: Specific activity of ATP7B and its variants reconstituted into asolectin liposomes estimated from 
single point measurements in MES buffer with 100 µM TCEP. All measurements were done in triplicates; reac-
tion time was 30 minutes. Specific activity is based on total protein amount in the purified samples. 
Statistics include 3 technical replicates. Standard error of the mean is indicated by error bars. 
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reported for human ΔMBD1-5ATP7B purified from S. cerevisiae (Portmann and Solioz, 2005), albeit 
in higher copper concentration. 
 
An assay with higher sampling frequency was needed to see the Pi accumulation details 
within the 10 minutes period (Fig. 4.21), because this enzyme shows much faster rates than ATP7B 
or Δ1-795ATP7B. The non-linear character of kinetic curves is traditionally explained by transported 
substrate depletion, ATP exhaustion or inhibition by the product of reaction. Substrate or ATP 
depletion is unlikely in our experimental system, 
but inhibition by ADP or Cu2+ is possible. 
The calculated initial rates for the puri-
fied enzymes measured in detergent are: 0.010-
0.015 µmol/min/mg for the full-length ATP7B, 
0.090-0.130 µmol/min/mg for Δ1-795ATP7B, and 
0.400-0.500 µmol/min/mg for ATP7B.K. These 
rates are based on quantities of the correspond-
ing proteins as assessed by SYPRO Ruby in-gel 
quantification. The numbers for activity of the 
full-length protein are similar to the measurements conducted by previous groups (Portmann and 
Solioz, 2005). 
 
Figure 4.20: Time course of Pi production by ATP7B and its two variants in MES buffer with 100 µM TCEP. 
Measurements were done in triplicates. Specific activity is based on amount of total protein in purified sample. 
 
Figure 4.21: Time course of Pi production by 
ATP7B.K in MES buffer with 100 µM TCEP, 
smaller time step. Measurements were done in trip-
licates. Specific activity is based on amount of total 
protein in purified sample. 
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First of all, it should be noted that the activity of ATP7B after purification is considerably 
lower than the activity that can be estimated from the microsomal measurements. It means that the 
enzyme is either severely inhibited by the purification process or detergent, or that it misses im-
portant yet unknown additional factors, which are absent in our in vitro system. The same holds 
true for ATP7B.K. Purified Δ1-795ATP7B shows activity rates comparable to those of the other two 
constructs even without added copper. 
4.4. Development of Copper Transport Assay for ATP7B Using CS-1 
Fluorescent Sensor 
The substrate transport activity of a membrane-embedded transporter molecule can be 
measured either in membrane vesicles (microsomes), or in liposomes. Measurements in the vesi-
cles require the transporter molecule to be unique in the organism used for expression, or the trans-
porter to have an efficient specific inhibitor so that a clear 
control experiment can be made. The advantage of this 
approach is that one does not have to purify the protein 
from the membrane. Liposomes, on the other hand, have 
an advantage of a strictly controlled environment. Be-
cause K. lactis has the intrinsic CCC2 copper transporter, 
we used the liposomes method. The most widely used ap-
proach for measurements of copper transport involves ra-
dioactive copper isotope 64Cu (Dancis et al., 1994; Solioz 
and Odermatt, 1995; Voskoboinik et al., 1998). However, 
this method is complicated by the fact that 64Cu half-life 
is only 12.7 hours, making such measurements logistically difficult. 
Thus, in order to study the copper transport properties of the ATP7B and its variants, we 
had to develop a novel method, which would rely on stable compounds and would be sensitive 
enough to detect slight changes in copper concentrations. 
CS-1 (Fig. 4.22) is a synthetic organic dye developed previously (Zeng et al., 2006). It was 
designed specifically for studies of copper in living tissues. It is water soluble and highly selective 
 
Figure 4.22: Chemical structure of CS-1 
(Li et al., 2005) 
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towards Cu+. It was found to be able to penetrate cell membrane and bind intracellular copper; 
CS1:Cu+ complex can be detected by fluorescence emission at 560 nm (excitation wavelength – 
540 nm). The complex of the dye with copper is charged and cannot cross the membrane. 
Preliminary studies conducted in our lab (O’Grady and Dmitriev, unpublished data) found 
that reducing agents, DTT in particular, quench the fluorescence of CS-1. We tested the CS-1 assay 
for compatibility with the MES buffer with ascorbate and TCEP that was used to measure ATPase 
activity of the ATP7B and its variants at the time of assay development. 
 
In MES buffer with 1 mM ascorbic acid and 0.1 mM TCEP (MES-AT) CS-1 showed a 
response to 1 µM and higher [Cu+] with maximum fluorescence at 556 nm (Fig. 4.23). In order to 
test whether CS-1 could also sense copper bound to ATOX1, we have tested the sensor in the same 
conditions with ATOX1 preloaded with copper. Fluorescence measurements of CS-1 with ATOX1-
Cu showed no significant fluorescent response from the sensor to copper bound to ATOX1 (Fig. 
4.24). This means that the binding affinity of ATOX1 for copper is much higher than that of CS-1, 
so the sensor cannot detect copper bound to ATOX1. 
 
Figure 4.23: Dependence of CS-1 fluorescence in response to various copper and copper-ATOX1 concentrations 
in MES-AT buffer. Copper concentrations are colour-coded with corresponding values displayed. CS-1 was used 
in 0.2 µM concentration. 
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Even though the sensor should bind copper in a 1:1 ratio, we still can observe a response 
even when the concentration of copper exceeds the concentration of CS-1. This may be because 
CS-1 appears to form colloid particles in solution (Dolgova and Dmitriev, unpublished data), thus 
lowering the effective concentration of the sensor. 
 
These findings led us to the idea that CS-1 might be a suitable in vitro copper probe for the 
studies of copper transport activity of ATP7B and its variants in proteoliposomes. In our system, 
copper is supplied to the ATP7B integrated into proteoliposomes by ATOX1. Outside proteolipo-
somes, all the copper is bound to ATOX1 and will not be detected by CS-1. ATP7B will accept 
copper from ATOX1 and transport it inside the proteoliposomes. Copper ions would not be able to 
cross the lipid bilayer back into the solution. Metal free CS-1 on the other hand is amphiphilic and 
will diffuse across the lipid bilayer into the proteoliposome lumen, where it will bind copper.  The 
CS-1 complex with copper is charged and cannot cross the lipid membrane. Thus, CS-1-Cu will 
be trapped inside the proteoliposomes and detected by fluorescence readout.  (Fig. 4.24). 
 
Figure 4.24: Principle scheme of CS-1 fluorescence copper transport assay. Before the start of the reaction cop-
per is bound to ATOX1. After the reaction is initiated by the addition of ATP, copper is pumped by ATP7B across 
the membrane into the proteoliposome. Uncharged free CS-1 can go across the lipid bilayer of a proteoliposome 
in both directions, while CS-1 that binds the intraliposomal copper stays inside and can produce fluorescent 
response to irradiation with green (540 nm) light. 
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Amphiphilic nature of CS-1 makes it necessary to take into account CS-1-lipid interactions. 
To investigate how CS-1 responds to copper in the presence of lipids, we tested CS-1 mixed with 
liposomes made of asolectin from soybean or polar lipid from rat liver. 
The behaviour of the sensor in the presence of liposomes was much more complex than 
without lipid. In the system with asolectin liposomes CS-1 showed a considerably lagged response 
to free copper (Fig. 4.25), while in the system with liver lipid there was a significant fluorescence 
of the sensor in the sample with ATOX1-bound copper (Fig. 4.26). 
The latter can be explained by the fact that ATOX1 may interact with liver lipids, so inter-
actions with lipid can change affinities of ATOX1 and CS-1 for copper, resulting in copper transfer 
from ATOX1 to CS-1 which was not observed in aqueous phase. The association of ATOX1 with 
lipids has been shown before (Flores and Unger, 2013). 
These results indicate that asolectin lipids are preferable to liver lipid for our transport 
assay because the latter stripped copper from ATOX1 increasing background fluorescence, which 
could further complicate the interpretation of data and would require more controls to be done. 
Also, it became apparent that the system needed about 10 min equilibration time before initiating 
the reaction, so that CS-1 would partition completely between aqueous and lipid phases and fluo-
rescence would stabilize. 
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Figure 4.25: Time course of CS-1 response to different combinations of asolectin, 5 µM ATOX1 and 3 µM Cu+ 
in MES buffer with 1 mM ascorbate and 0.1 mM TCEP. CS-1 was 0.3 µM. Each reaction contained 625 µg of 
lipid in 1 mL volume. Fluorescence emission at 556 nm was measured at 1 second interval. 
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Figure 4.26: Time course of CS-1 response to different combinations of liver lipid, 5 µM ATOX1 and 3 µM Cu+ 
in MES buffer with 1 mM ascorbate and 0.1 mM TCEP. CS-1 was 0.3 µM. Each reaction contained 625 µg of 
lipid in 1 mL volume. Fluorescence emission at 556 nm was measured at 1 second interval. 
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Even with the equilibration stage, the change in fluorescence response between samples 
supplemented with ATP and control samples was negligible (Fig. 4.27), and it was not possible to 
detect ATP-dependent copper transport activity. One possible reason is that the CS-1 sensitivity is 
insufficient to detect small change that was produced by ATP7B. An additional serious complica-
tion is the complex interactions of the CS-1 and the lipids, which could mask or alter the fluores-
cent response of the sensor. Quite a low amount of protein that was available for several repeated 
measurements and relatively big reaction volume (minimum 0.5 mL) may be the other reasons for 
undetectable change in fluorescence. 
4.5. Detection of the Putative Copper Transporter PINA in Rat Pineal 
Gland 
PINA is a putative truncated version of ATP7B. Its mRNA was detected in extracts of pin-
eal gland of R. norvegicus. Its domain composition predicted from the mRNA sequence is rather 
 
Figure 4.27: Time course of CS-1 response to transport activity of ATP7B reconstituted into asolectin liposomes 
in MES-AT buffer. ATOX1 was 5 µM, Cu+ was 3 µM, CS-1 was 0.3 µM. Each reaction contained 128 µg of 
lipid and 1.28 µg of incorporated ATP7B in 0.6 mL volume. Measurements with and without ATP were done in 
triplicates (displayed). Arrow indicates moment of ATP or buffer addition, with a spike produced due to mixing 
with a pipette. Fluorescence emission at 556 nm was measured at 2 seconds interval. 
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unusual: the whole N-terminal segment containing metal-binding domains and first four trans-
membrane helices is missing. To establish whether this mRNA is translated into a protein in vivo, 
we tried to detect PINA in the pineal gland tissue by Western blotting. First we tested if the com-
mercially available antibodies against C-terminus of ATP7B have sufficiently high sensitivity and 
specificity to detect the ATP7B protein expressed at a basal level in tissue extracts. The rat liver 
tissue is a good benchmark for ATP7B detection, because this enzyme is expressed there at high 
level compared to other tissues. Also, rat liver is much larger than pineal gland and therefore pro-
vides more material for antibody testing. 
 
Several commercial antibodies against rat ATP7B are available. These are mostly polyclo-
nal antibodies against the characteristic C-terminal tail of the enzyme, and should detect both for 
 
Figure 4.28: Testing antibodies for ATP7B detection in rat liver tissue. Rat liver homogenate and membranes 
were loaded on SDS polyacrylamide gel (10 µg of total protein per lane). 
RH – rat liver crude homogenate; RM – rat liver crude membrane fraction. 
A – Coomassie staining; B – anti-ATP7B (Santa Cruz H-94 polyclonal) + anti-rabbit IgG (ThermoFisher Scien-
tific); C – anti-rabbit IgG only; D – anti-ATP7B (Boster Bio PA2262 polyclonal) + anti-rabbit IgG. Orange boxes 
indicate the region where a band corresponding to ATP7B is expected 
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the full-length ATP7B and PINA. We have tested polyclonal antibodies manufactured by Santa 
Cruz Biotechnology (California, USA) designated “H-94”, and Boster Bio (California, USA) des-
ignated “PA2262” (Fig. 4.28). Only a faint signal from the area of interest has been detected in rat 
liver crude membrane fraction by antibody obtained from Boster Bio, while the antibodies from 
Santa Cruz were unable to detect the protein in the liver tissue at all. However, both antibodies 
successfully detect the overexpressed ATP7B.K recombinant protein from humans (Fig. 4.29), and 
the manufacturer specifications indicate that the antibodies are suitable for rat ATP7B as well. The 
identity of epitope sequences for the H-94 antibody is 84% (epitope length 94 amino acids, 17 
amino acids difference) and 81% for the PA2262 antibody (epitope length 16 amino acids, 3 amino 
acids difference). Thus, it was decided to check the pineal gland tissue. 
 
Pineal gland tissues were obtained from Sprague-Dawley rats, kept at a controlled 12:12 h 
day-night cycle, at various time points during the light and dark periods. When collecting dark 
period samples, special care was taken to protect animals from accidental exposure to light: cages 
were transported to a procedure room under a non-transparent cover, and the procedures were 
 
Figure 4.29: Western blot of ATP7B.K in whole cell extracts of K. lactis cells. S – anti-ATP7B H-94 from Santa 
Cruz Biotechnology + anti-rabbit IgG (ThermoFisher Scientific); B – anti-ATP7B pa2262 from Boster Bio + 
anti-rabbit IgG (ThermoFisher Scientific); SE – non-transformed yeast whole cell extract stained with H-94 
antibody + anti-rabbit IgG. The arrow indicates the ATP7B.K band. 
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carried out under red light, which has no effect on photodetection system that regulates the circa-
dian processes (Okano and Fukada, 2001). 
The Santa Cruz antibody produced a signal at the expected molecular weight of approxi-
mately 70 kDa (Fig. 4.30), which consisted of three closely spaced bands, where the upper and the 
lower band did not show any variation, while the middle band did show a slight intensity increase 
in the dark period samples (11 pm – 4 am). 
 
To confirm that the PINA is represented by one of the bands, the region of a gel that con-
tained the triple band was cut out and bands were sent for identification by in-gel tryptic digest 
 
Figure 4.30: Western blot of rat pineal gland tissue extract, anti-ATP7B (Santa Cruz Biotechnology). The har-
vesting time of the samples is indicated above the lanes; lanes represent samples from different animals. Anti-
GAPDH antibody was applied to the lower part of the membrane as a loading control. 
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fingerprint. The results indicated presence of the following proteins: heat shock protein HSP72, 
transketolase, rat serum albumin precursor, V-type proton ATPase, periplakin, PHD finger protein 
21B, dynamin and several automatically predicted proteins. No peptide fragments of copper-trans-
porting P-type ATPases were detected. 
In the next experiment, the H-94 and PA2662 antibodies were used to detect PINA in pineal 
gland membrane fraction. Isolating membrane fraction was intended to enrich for membrane-lo-
cated putative PINA protein, and as a result get a clear expression pattern on the Western blot. 
Unfortunately, there was no signal from the PA2262 (Fig. 4.31, panel A), and very weak residual 
signal from the H-94 (Fig. 4.31, panel B) that resembled that of the tissue extracts. 
 
Inability to reliably detect the PINA protein in the pineal gland extracts and membrane 
fraction can be explained by the small amount of material that can be obtained from a rat pineal 
gland, which is usually not larger than 1 mm in diameter and 3 mg in weight. If PINA is a low-
abundance protein, like ATP7B, there is a high chance it would not be detected with antibodies 
without additional enrichment methods, such as immunoprecipitation. However, getting sufficient 
amount of material for the immunoprecipitation from rat pineal glands poses difficulties due to the 
size of the organ, and hence a large number of experimental animals needed. 
 
Figure 4.31: Western blot of rat pineal gland membrane fraction. 1-5 – samples from different animals. Panel A: 
Western blot with PA2262 anti-ATP7B antibody (BosterBio) + anti-rabbit IgG-HRP conjugate (ThermoFisher 
Scientific). Panel B: Western blot with H-94 anti-ATP7B antibody (Santa Cruz Biotechnology) + anti-rabbit IgG-
HRP conjugate (ThermoFisher Scientific). 
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5. Discussion 
The putative pineal night-specific ATPase PINA is a peculiar splice variant of ATP7B, 
which lacks 795 amino acids of N-terminus. The goals of this project were: 1) to find out whether 
the putative PINA protein is translated from its mRNA in the rat pineal gland, 2) to find out whether 
the protein levels follow diurnal cycle observed for PINA mRNA, 3) to find out whether this pro-
tein is a functional copper-transporting ATPase, and 4) if it is a functional enzyme, to establish 
whether its enzymatic activity compares to that of the full-length ATP7B. 
We were unable to conclusively establish the existence of PINA protein in vivo, however 
our data show that such a protein can exist, because it was expressed and incorporated into mem-
brane in K. lactis host, and showed enzymatic activity. This encouraged us for further studies of 
properties of truncated proteins. To compare the enzymatic activity of recombinant PINA with the 
full-length protein, the full-length ATP7B was purified. Although several functional studies on 
ATP7B have been conducted to date (Hung et al., 1997; Forbes et al., 1999; Tsvikovskii et al., 
2001; Lutsenko et al., 2003; Portmann and Solioz, 2005; Pilankatta et al., 2009), no successful 
purification of the full-length human ATP7B has been reported to date. In this study, we were able 
to design and fine-tune purification procedure of this protein expressed in K. lactis cells so we 
could purify the full-length human ATP7B and study its activity for the first time. The ATP7B gene 
was modified to produce two truncated constructs: ATP7B.K (putative human PINA mRNA found 
in the GenBank) with a characteristic 18 a.a. deletion, and Δ1-795ATP7B, a protein essentially ho-
mologous to the rat PINA, without the deletion predicted in ATP7B.K. The purified proteins were 
active, and we were able to characterize their ATPase activity. 
5.1. Expression of ATP7B and its Variants 
Full-length human ATP7B has been expressed previously in several eukaryotic expression 
systems, such as mammalian cells (Lockhart and Mercer, 2001; Voskoboinik et al., 2001; Pilan-
katta et al., 2009), insect cells (Tsvikovskii et al., 2002; Barnes et al., 2005) and yeast (Hung et 
al., 1997; Iida et al.., 1998; Forbes et al.., 1999; Portmann and Solioz, 2005). Characterization of 
functional properties of endogenously expressed ATP7B in human cells appeared to be difficult 
due to very low expression levels (Beck et al., 2011), while insect cells expression system could 
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produce much larger quantities of functional protein (Tsvikovskii et al., 2002). A full-length human 
ATP7A enzyme was purified from insect cells (Hung et al., 2007). Only the yeast system was used 
to produce truncated human ATP7B protein for further purification (Portmann and Solioz, 2005). 
Yeast expression systems have big advantages in terms of costs accompanying production of suf-
ficient quantities of a protein for purification. It should be noted, however, that only a protein 
lacking MBD1-5 was expressed and purified from S. cerevisiae, while only CCC2 complementa-
tion assays were performed on the full-length protein. 
Upon expression in K. lactis cells recombinant full-length ATP7B, as well as ATP7B.K and 
Δ1-795ATP7B, were successfully incorporated into the membrane, as confirmed by Western-blot 
analysis of membrane fractions of transformed yeast. Proper expression and folding of ATP7B and 
ATP7B.K were assessed in vivo by inducing intracellular trafficking by treating yeast cells with 1 
mM CuCl2 and subsequent immunofluorescent labelling with fluorescent antibodies. The experi-
ments showed that ATP7B prominently relocalizes from Golgi to the plasma membrane in the 
yeast cells in response to elevated copper, which suggests proper folding and regulation of the 
protein in the cell. The localization of ATP7B.K in response to CuCl2 changes too, however, the 
change is more subtle. In response to high copper, the truncated protein also tends to go to the 
plasma membrane, although to a smaller extent than the full-length ATP7B. The pattern of protein 
distribution seen in the cytoplasm changes too (Fig. 4.2). 
The conclusion on cellular compartment localization of the protein can be drawn with the 
help of membrane fractionation experiment (Fig. 4.3). A heavier membrane fraction, which was 
not detectable in the untreated cells, appeared at the 50-65% interface on the sucrose gradient in 
the cells treated with copper. A typical response of a cell to toxic copper levels is to activate export 
of the metal ions from the intracellular space. In mammalian cells, ATP7B normally drives copper 
transport into the exocytic vesicles, which then fuse with the plasma membrane excreting copper 
outside the cell (Cater et al., 2006). Hence, it is possible that the 50-65% fraction that appears in 
copper-treated cells is a heavy protein-loaded vesicular fraction. Relatively higher amount of 
ATP7B.K in this fraction indicates that this protein when expressed in yeast tends to localize into 
these exocytic vesicles to a greater extent than ATP7B. 
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The copper toxicity study showed that the yeast expressing ATP7B were in fact more sus-
ceptible to copper than those that expressed the truncated constructs or only the intrinsic copper 
ATPase CCC2. The possible reason for that is that overexpression of ATP7B suppresses the intrin-
sic CCC2, but ATP7B cannot properly integrate into yeast copper metabolism. An example of 
downregulation of the host protein expression by a homologous recombinant proteins has been 
reported previously (Napoli et al., 1990). If CCC2 is downregulated, it is possible that ATP7B is 
incapable of efficient loading of CCC2 targets, such as yeast SOD, which can lead to higher sen-
sitivity towards free radical damage caused by high copper concentration. Also, inability to 
properly integrate into the yeast copper metabolism can be due to structural differences between 
CCC2 and ATP7B, in particular in the N-terminal region. ATP7B has six metal-binding domains 
versus only two in CCC2, so yeast cells may lack proper regulation mechanisms for such an en-
zyme. 
Trafficking of the proteins inside the cells in response to high copper concentration signi-
fies proper folding and insertion of the full-length ATP7B and its variants into membranes, which 
opens way to functional studies of these enzymes. 
5.2. Purification of ATP7B and its Variants 
Purification of membrane proteins is generally more challenging than purification of solu-
ble proteins. First, a membrane protein has to be extracted from the membrane. This is done using 
detergents, which are chosen empirically for each protein. Cost and application suitability (i.e. 
crystallographic studies, activity studies, NMR studies, etc.) are important factors in choosing de-
tergents for screening. Previous reports (Portmann and Solioz, 2005) indicated that ΔMBD1-5ATP7B 
could be solubilised from S. cerevisiae membranes by DDM, but only after copper treatment of 
the yeast cells. We were unable to solubilise either full-length ATP7B or truncated proteins in 
DDM, either with or without copper treatment. There are two possible explanations for this fact. 
First, in K. lactis the proteins may have a different lipid environment. Second is that our protein 
constructs are different. Even similar proteins may require different detergents. Among several 
tested detergents, LMPG was the most effective for solubilisation of ATP7B, ATP7B.K and Δ1-
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795ATP7B. Moreover, structurally it is much more similar to membrane phospholipids than other 
widely used detergents as DDM or Triton X-100.  
All proteins were successfully purified by affinity chromatography on Ni-NTA agarose and 
subsequent size exclusion chromatography. Truncated constructs were obtained using slightly 
modified protocol of ATP7B purification. 
Because truncated constructs were expressed at a lower level than ATP7B, they were puri-
fied from the crude membranes to increase protein yield. Sucrose gradient separation was benefi-
cial for the full-length ATP7B purification, helping to achieve better purity. Although membrane 
fractionation on sucrose gradient helps to improve protein purity, it leads to increased losses of the 
protein of interest. We found that 0.2% of LMPG in the buffer used in affinity and size exclusion 
chromatography is preferred for the truncated constructs, while 0.1% is sufficient for ATP7B. This 
can be explained by higher hydrophobicity of the truncated constructs, because they lack a very 
big soluble component on the N-terminus. The affinity purification on Ni-NTA agarose alone pro-
duced proteins of very low purity (as low as 6% purity for the truncated versions), so additional 
size exclusion step was necessary. It helped to increase purity of ATP7B to 80%, and truncated 
constructs – to 50%. Additional benefit from the size exclusion step was that imidazole was sim-
ultaneously removed from the protein, so no separate buffer exchange or dialysis step was needed. 
The final purity obtained after the size exclusion chromatography is lower for the truncated 
constructs than for the full-length ATP7B due to the lower expression level of the truncated con-
structs in comparison to the full-length protein. Another reason is the location of the His-tag in the 
truncated constructs: it is attached directly to the A-domain, versus attachment to the flexible N-
terminus of the full-length protein. This leads to weaker binding of the truncated constructs to the 
Ni-NTA agarose in comparison with the full-length ATP7B, which leads to elution of the truncated 
constructs with more contaminants. The purification method we developed yields up to 0.15 mg 
of ATP7B, and up to 0.08 mg of ATP7B.K or Δ1-795ATP7B per 1 L of yeast culture. 
5.3. Enzymatic activity of ATP7B variants. 
The enzymatic activity of copper-transporting P-type ATPases has been mostly studied in 
vivo, or in membrane vesicles, although reconstitution into proteoliposomes has also been done 
74 
for ATP7B lacking several metal-binding domains (Portmann and Solioz, 2005). There are no pub-
lished studies of the enzymatic activity of purified full-length ATP7B or constructs similar to 
PINA/ATP7B.K. All previous measurements of the full-length ATP7B activity have been done in 
membrane vesicles from insect cells (Tsvikovskii et al., 2002; Barnes et al., 2005) and mammalian 
cells (Voskoboinik et al., 2001; Lockhart and Mercer, 2001; Pilankatta et al., 2009). Comparative 
analysis of phosphorylation/dephosphorylation rates of human copper ATPases in membrane ves-
icles from insect cells (Barnes et al., 2005) suggested 6 times lower turnover rates of ATP7B in 
comparison with ATP7A. Pilankatta and coworkers (Pilankatta et al., 2009) were able to evaluate 
specific activity of the recombinant human full-length enzyme in microsomal fraction of COS 
(simian) cells. Their measurements showed activity of 0.030 µmol/mg of total microsomal pro-
tein/min. To date, one study of enzymatic activity of purified truncated ΔMBD1-5ATP7B has been 
done (Portmann and Solioz, 2005). In that study, the purified protein ATPase activity was studied 
using the malachite green assay. Copper transport activity was studied for murine ATP7B using 
radioactive copper isotope, 64Cu, detection in microsomes from CHO cells (Voskoboinik et al., 
2001), and was shown to be 0.0001 µmol Cu/mg of total microsomal protein/min. 
Although the assay employing 32P labelling with subsequent molybdate-benzene extraction 
and analysis by scintillation counter is the most sensitive phosphatase assay available, we, as well 
as other groups who aimed to establish specific activity of the enzyme, chose colourimetric ap-
proach, because it is easier and quicker to conduct and does not involve radioactive materials. 
ATPase activity measurements in microsomes indicated that the full-length ATP7B is ac-
tive in the yeast membranes, and the putative human PINA homologues, Δ1-795ATP7B and 
ATP7B.K, are active ATPases. The turnover rate of ATP7B.K and copper-activated Δ1-795ATP7B 
in microsomes is most likely higher than that of the full-length ATP7B because the amount of the 
overexpressed truncated protein in membranes is approximately two times smaller than of the full-
length protein. 
Our measurements of purified ATP7B ATPase activity (0.010-0.015 µmol/mg/min) pro-
duced results similar to those reported before (0.004-0.008 µmol/mg/min in purified reconstituted 
ΔMBD1-5ATP7B by Portmann and Solioz, 2005). That experiment was done in similar conditions 
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(pH 6.0, 37°C, added copper in micromolar range). Specific ATPase activity of ATP7B in our and 
previous experiments lies in the same order of magnitude. The difference in these measurements 
can arise from various factors such as protein medium (liposomes, detergent, buffer composition), 
and purification procedure. The turnover number – 1.6-2.4 min-1 – of ATP7B is small in compari-
son with such fast ATPases as SERCA1 – 2700 min-1 (Lytton et al., 1992) or Na/K-ATPase – 1900 
min-1 (Sweadner, 1985). This is explained by different physiological roles of these ATPases: 
SERCA and Na/K-ATPase need fast reaction rates to regulate fast processes, such as muscle con-
traction and neural signal transduction. Copper levels, on the other hand, do not change dramati-
cally fast, and copper concentration in the cell is very low. 
The purified putative human PINA homologue ATP7B.K has the highest activity of 0.400-
0.500 µmol/min/mg (turnover number – 27.7-34.6 min-1), nearly 15 times higher than the purified 
full-length protein. Δ1-795ATP7B, unlike in microsomes, is active even in the absence of added 
copper and has somewhat lower specific activity of 0.090-0.130 µmol/min/mg (turnover number 
– 6.4-9.3 min-1), approximately 4 times faster than the full-length enzyme. Apparently, in the mi-
crosomal environment Δ1-795ATP7B is downregulated when the concentration of copper is very 
low, either by lipid environment or proteins which can associate with it. These inhibiting factors 
may be removed during purification. 
The truncated constructs have significantly higher activity than the full-length ATP7B. This 
may be explained by structural differences between ATP7B and truncated variants. For example, 
MBDs of N-terminus has been shown to interact with the N-domain of ATP7B (Tsvikovskii et al., 
2001). It has further been shown that MBD1-4 can have an inhibitory effect on ATP7B, while 
deletion of these domains led to acceleration of the catalytic cycle (Huster and Lutsenko, 2003). 
The cytoplasmic entrance for copper ions as well as the exit are formed by helices that are missing 
in the truncated constructs. When these helices are missing, the main copper-binding site(s) be-
come much more accessible, which could increase the rate of ion translocation across the mem-
brane. Normally, the rate of ion translocation is tightly coupled to the rate of ATP hydrolysis, so in 
case of increased ion translocation rate the rate of ATP hydrolysis would increase as well. Alterna-
tively, deletion of several helices could result in uncoupling of ion transport and ATPase activity – 
it is known that structural alterations in P-type ATPases can lead to such phenomenon (Andersen 
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and Vilsen, 1995; Lutsenko and Kaplan, 1995; Bramkamp and Altendorf, 2005). Fast rates of 
ATP7B.K may be additionally explained by the 18 a.a. deletion present in its M-domain, mainly 
involving the extracellular loop (Fig. 2.11). This deletion probably further activates the enzyme, 
and is important for regulation of its activity in the microsomes, as compared to Δ1-795ATP7B 
without the deletion, which requires higher copper concentration for activation. 
Another peculiarity is that the reaction product accumulation curves are nonlinear. Accord-
ing to our observations, the faster the enzyme, the faster the reaction ceases. Typically, time-de-
pendent activity decrease is observed either because of transported substrate depletion, depletion 
of ATP or inhibition by ADP, but in our assay conditions both these scenarios seem unlikely. Less 
than 0.1% of added ATP, was hydrolyzed by the time the reaction reached a plateau. Copper supply 
cannot be a limiting factor either, because the reaction is carried out in detergent, not in the lipo-
somes, so even low amounts of copper would be “recycled” many times instead of being seques-
tered in the liposomes. We have calculated the maximum number of enzyme cycles of ATP7B.K 
and Δ1-795ATP7B to be around 200, after which the enzymes halt. We are unsure about the reasons 
behind such behaviour. Because decrease in the reaction rate is determined by the number of en-
zyme turnovers, rather than time, a logical conclusion could be that the proteins are inhibited by 
either some product of reaction (such as oxidized copper (II)), or by changes in the redox potential. 
We did not observe activation by added copper for any of the three constructs when they 
were purified and tested in detergent, which is most likely accounted for by the effect of the resid-
ual copper in reaction buffer. ATP7B as well as bacterial copper transporter CopB have been pre-
viously shown to display basal activity even in absence of any added copper (Wyler-Duda and 
Solioz, 1996; Bissig et al., 2001; Tsvikovskii et al., 2001; Portmann and Solioz, 2005). 
The measurements of the ATPase activity in the membranes of transformed yeast, however 
inaccurate in terms of specific activity with regard to expressed proteins amount, suggest that pu-
rification process and/or detergent has severely adverse effect at the full-length ATP7B and its 
variants, because prior to purification their activity seem to be very much higher. Detergents are 
known to inhibit enzymes during and after purification (Carpenter et al., 1990; Kurkela et al., 
2002). 
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The rate of transport of copper ions across a lipid bilayer is another important property of 
a copper-transporting ATPase. The traditional method of measuring copper transport employs ra-
dioactive 64Cu isotope. It was not our first method of choice due to the short isotope half-life time, 
logistical difficulties, and labour-intensive nature of such analysis. 
Instead, we set out to design a method based on nonradioactive compounds, which would 
be sensitive enough to study copper-transporting activity of ATP7B and its variants. CS-1 fluores-
cent sensor gave promise as a sensitive, non-toxic and very specific to copper (I). 
Unfortunately, we were unable to detect copper transport in liposomes with incorporated 
ATP7B using the developed method. One of major complications that we encountered was com-
plex interactions of the amphiphilic sensor with lipids. These interactions result in prolonged (10 
minutes or even longer) nonlinear fluorescence dynamics that can easily obscure slight changes in 
dye fluorescence caused by copper binding. As ATP7B is a relatively slow ATPase, the change in 
free copper concentration is probably very small, and the sensitivity of the sensor in the presence 
of lipids and TCEP is insufficient to provide a detectable signal. Considering the prolonged period 
of system equilibration (10 minutes) before adding ATP, the protein might partially lose its activity. 
Large reaction volume (minimum 0.5 mL) together with modest quantities of available protein 
complicate the measurements even further. 
Thus, the method of detection of ATP-dependent copper transport by CS-1 need extensive 
further development in order to be suitable for measurements of copper transport activity in recon-
stituted proteoliposomes. For example, a different equipment could be used, where the reaction 
volume can be small, so the proteoliposomes would be less diluted. Different lipid composition of 
liposomes may also positively contribute to the assay behaviour. Buffer composition may also play 
a role: various reducing agent may have different effects on the fluorescent sensor. Once the 
method is optimized sufficiently, it may become a useful tool to study copper transport in real-
time. 
5.4. Putative PINA ATPase Detection in Rat Pineal Gland 
Although PINA mRNA was found, there’s no direct evidence for the existence of corre-
sponding protein. In order to find out whether the PINA mRNA is translated into protein in rat 
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pineal gland, and whether its translation follows the pattern of mRNA expression – abundant at 
night and undetectable at day – reported by Borjigin and coworkers (Borjigin et al., 1999), analysis 
of pineal gland tissue taken from experimental animals by Western blot analysis was performed. 
Because PINA is identical to the C-terminal half of the full-length ATP7B, antibodies against the 
C-terminus of ATP7B should also detect PINA. As PINA is presumably expressed at night, we 
expected to detect antibody signal in the samples of pineal glands taken during the dark period. 
A limiting factor in protein detection by Western blot is sensitivity and specificity of the 
primary antibodies. A band at the apparent molecular weight of PINA was detected in pineal gland 
tissue extracts with H-94 antibodies (Santa Cruz Biotechnology, Dallas, TX), and did show some 
diurnal variation. Non-specific reaction was also observed in the same molecular weight and range. 
No protein was detected with either H-94 or PA2262 antibodies (Boster Bio, Pleasanton, CA) in 
the isolated membrane fraction from pineal gland, so the protein detected in tissue extracts appears 
to be cytoplasmic rather than membrane bound. Mass spectrometry analysis failed to detect any 
PINA derived peptides. 
Because both antibodies we used successfully detect the protein overexpressed in yeast, 
the most likely reason for the failure to detect PINA is low sensitivity of both antibodies. H-94 
antibodies were unable to detect ATP7B in liver extracts and membranes, PA2262 antibody also 
was insufficiently sensitive. The detection is further complicated by the very small size of a rat 
pineal gland, and as a result, very small amount of material for analysis. The most straightforward 
way to fix this problem would be to use more animals to obtain more material, but such an ap-
proach is questionable both from financial and ethical points of view. One of the possible solutions 
to overcome detection limitations would be to either use a pineal gland from a larger animal (i.e. 
pig). This, however, would require prior search for PINA mRNA in that tissue, because this splice 
variant is not necessarily common for all animals. Another way to study PINA expression pattern 
could be culturing rat pinealocytes: it would be possible to grow more material in a controlled 
environment. Also, production or ordering of custom antibodies specially for the purpose of de-
tecting PINA/ATP7B in tissue extracts is an option. Raising antibodies against a different epitope 
and selecting for the most sensitive ones might produce better results. 
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Even though we could not show the expression of PINA in the tissue, a recent finding 
(Dolgova and Dmitriev, unpublished data) shows that copper content in night pineal glands is no-
ticeably higher than in day pineal glands. Since copper concentration in the pineal gland appears 
to fluctuate according to the circadian rhythms, pineal gland should contain a diurnally regulated 
copper transporter. This suggests that a putative PINA protein indeed has a possible physiological 
role. To understand the role of this protein, as well as the role of copper in pineal gland, further 
studies are needed, because current knowledge is scarce. Little is known about the function and 
role of splice variants of ATP7B. At least one case of alternative splicing, which removes exon 12 
from the protein, has been shown to serve a “reparative” function in patients with 2810delT muta-
tion, which makes the protein defective. Patients with this mutation were found to have an in-
creased level of alternative splicing at the exon 12 (linker region between A-domain and TM3), 
omitting it completely, and thus partially rescuing the phenotype: ATP7B without exon 12 was 
shown to retain 80% of its activity, possibly accounting for mild symptoms of the Wilson’s disease 
in such a case (Wan et al., 2010). Another truncated 140 kDa version of ATP7B has been detected 
in mitochondria of cultured human hepatic cells, and it was suggested to take role in maintaining 
mitochondrial copper homoeostasis (Lutsenko and Cooper, 1998). It has been reported before that 
TMA and TMB are frequently absent in brain-specific splice variants of ATP7B, and that the brain 
has the biggest number of shorter splice variants than other tissues (Petrukhin et al., 1994). The 
greater variation in splice variants of ATP7B in brain can be required for tighter control of copper 
levels, as the brain has low levels of antioxidants and antioxidant enzymes, but high levels of 
metals (Telianidis et al., 2013). 
Copper involvement in circadian rhythms is not well-studied either. It has been shown, 
however, that mice knockouts of PrPC protein, post-translational modification of which leads to 
prion diseases, had only 20% of normal copper content in membrane fractions from brain tissues 
(Brown et al., 1997), and that such mice had alterations in their circadian behaviour (Tobler et al., 
1996). There’s evidence of diurnally varying copper levels in serum in human, with concentrations 
of the metal above mean at daytime and below mean at nighttime (Lifschitz and Henkin, 1971). 
Existence of copper-dependent diurnal oscillator is speculated in plants (Peñarrubia et al., 2010). 
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Thus, pineal gland indeed may possess a copper-related diurnal cycle involving the putative 
PINA protein. Further studies are needed to establish its existence and role. 
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6. Conclusions 
For the first time, full-length human ATP7B was successfully over-expressed in yeast host, 
extracted from membrane and purified. Truncated constructs – ATP7B.K (a putative human PINA 
homologue with a predicted peculiar 18 a.a. deletion) and Δ1-795ATP7B (a putative human PINA 
homologue without the deletion) – were successfully created, over-expressed, extracted and puri-
fied. The enzymes were shown to fold and traffic inside cells in response to elevated copper con-
centrations. All three proteins, – the full-length ATP7B, Δ1-795ATP7B and ATP7B.K, were active 
in the host microsomes. The purified proteins display ATPase activity and the truncated constructs 
have much faster rates in detergent than the full-length protein. Successful expression and purifi-
cation of active ATP7B.K proves the possibility of existence of a structurally distinct and physio-
logically significant variant of ATP7B. 
The copper transport activity measurements using CS-1 fluorescent sensor did not succeed, 
likely because of previously unknown complex behaviour of the sensor in presence of lipids (lip-
osomes and proteoliposomes) and relatively slow turnover rate of ATP7B. The protocol needs 
further optimizations; alternative methods also should be considered (for example, use of 64Cu 
isotope in K. lactis knockout on CCC2). 
We were unable to detect PINA protein in the pineal gland, possibly due to the limited 
amount of material and insufficient antibody sensitivity. This may be overcome by developing 
very specific and sensitive antibodies tailored to this task. Alternative option is to switch to a dif-
ferent source of material (for example, pig pineal gland or cultured rat pinealocytes). 
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7. Future Directions 
Copper transport activity assay using CS-1 should be optimized, or a more sensitive assay 
for copper transport activity of purified ATP7B and its truncated versions should be conducted in 
order to fully characterize the properties of the enzymes. 
A separate confirmation of PINA mRNA in rat pineal gland and retina would be useful, as 
it was reported only once. Alternative strategy for establishing whether PINA is translated in pineal 
could be considered. One of such alternatives could be a pinealocyte culture – with it, it is possible 
to grow as many cells as needed without need for large quantities of animals. Because pinealocytes 
receive light information via norepinephrine signalling, it can be used in the culture medium to 
simulate the diurnal cycle. 
Further optimization of activity assay conditions is possible. Certain lipid environments, 
and buffers can be more beneficial for the enzymes to work. 
Crystallographic studies of ATP7B, Δ1-795ATP7B and ATP7B.K could be further consid-
ered after the optimization of expression and purification procedure, because only highly pure 
proteins are suitable for crystallography. 
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